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ABSTRACT
Structural and biochemical studies of the DNA replication initiation mechanism of the second
chromosome of Vibrio cholerae
By
Natalia Orlova
Advisor: Dr. David Jeruzalmi
Transmission of genetic information through DNA replication is one of the key
processes for any living organism. Despite the extensive effort put into studies of the
mechanism of DNA replication, the understanding of the process on the molecular level
is still incomplete. Specifically the molecular details of the very first events of DNA
replication initiation are not sufficiently understood.
The majority of bacteria possess a single circular chromosome, and in order to
initiate DNA replication these organisms utilize a conserved system, consisting of a
specific DNA sequence - replication origin, called oriC, and replication initiator protein
DnaA. However, bacteria with multipartite genomes evolved distinct systems to initiate
replication of secondary chromosomes. In Vibrio cholerae, and in related species,
secondary chromosome replication requires specific origin of replication, OriCII, and
unique initiator protein, RctB, which shares no sequence similarity with other initiator
proteins.
Previous structural studies of bacterial DNA replication initiation were conducted
in two kinds of systems: bacterial primary chromosomes and bacterial plasmids; these
studies have been challenging, and there are still many opened questions to date. No prior
structural work was done in order to elucidate mechanism of DNA replication initiation
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in secondary bacterial chromosomes, such as DNA replication initiation conducted by
RctB-oriCII system. The work described in this dissertation is dedicated to structural
studies of RctB-oriCII system. The structures of all four RctB domains were solved using
X-ray crystallography and biophysical and biochemical analyses of RctB-DNA
complexes were conducted. This work produced first structural view for the secondary
chromosomal DNA replication initiation machinery and laid out a strong foundation for
future structural studies of RctB-OriCII complexes.
We demonstrate that RctB consists of four domains. The structure of its central
two domains resembles that of several plasmid replication initiators. RctB contains at
least three DNA binding winged helix turn helix motifs, and mutations within any of
these severely compromise biological activity. In the structure, RctB adopts a head-tohead dimeric configuration that likely reflects the arrangement in solution. Therefore,
major structural reorganization must accompany complex formation on the head-to-tail
array of binding sites in oriCII. These findings support the hypothesis that the second
Vibrionaceae chromosome arose from an ancestral plasmid, and that RctB may have
evolved additional regulatory features.
The structural and biophysical data obtained in the course of this work allowed us
to develop a model of the macromolecular complex that several molecules of RctB form
on replication origin of the secondary Vibrio cholerae chromosome.
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CHAPTER 1 – INTRODUCTION
1.1 DNA REPLICATION IS A KEY PROCESS FOR ANY LIVING CELL
The genetic code of any organism is stored in the DNA. DNA forms a very stable
double-stranded structure, and the stability of its structure ensures the safety of the
genetic code. DNA should remain double-stranded at all times to ensure the optimal
stability of the structure and ultimately the safety of the genetic information.
There is a limited number of naturally occurring events that require separation of
the two DNA strands: replication, transcription, recombination, and repair. DNA
replication is a process of critical importance for any living organism, since accurate
transmission of genetic information is necessary for the survival of its species. If a DNA
strand becomes damaged, the second strand will serve as a template for the reconstitution
of the damaged strand. It is, therefore, not surprising that the initiation of DNA
replication has to be tightly regulated to avoid unnecessary events of DNA strands
separation. DNA replication is initiated when a specialized protein, an initiator, binds to a
specific DNA locus, the replication origin (1). In different species, the initiator protein
forms either a homomeric or heteromeric complex on the replication origin. After the
complex has been fully assembled, another protein, a helicase, binds DNA and actively
unwinds the DNA duplex (1). The overall mechanism of DNA replication initiation is
similar in all organisms, but protein factors involved in the process vary.
1.2 DNA REPLICATION INITIATION OF BACTERIAL CHROMOSOME
Although, at the molecular level, the mechanism of DNA replication initiation is
not completely understood, studies of the Escherichia coli chromosomal replication
system provide insight into the process. In the Escherichia coli system, the origin of
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replication is called oriC, and the initiator protein is DnaA. Initiation of DNA replication
begins when several copies of the DnaA protein bind to oriC, which leads to the initial
DNA strand separation. The DnaA protein is conserved among bacteria, suggesting that
the chromosomal replication mechanism is similar in various bacterial species (1,2).
E. coli and the majority of bacteria possess one single circular chromosome,
however, this genomic organization is not universal. Some bacterial species have more
than one chromosome, for example, Vibrio cholerae has two circular chromosomes (3).
Replication initiation of the first, larger chromosome in V. cholerae, requires the
conserved DnaA initiator. Unlike the larger chromosome, the smaller chromosome
requires a unique initiator protein, RctB (3). The initiator protein for replication of the
second chromosome is a unique factor, RctB (3).
In addition to chromosomal DNA, bacteria have extrachromosomal DNA in the
form of circular plasmids. Most plasmids encode a specific initiator protein, which is
required for initiation of plasmid replication (4). Therefore, in total there are three
different types of bacterial replication systems: replication system of the primary (most
often the only) chromosome, replication system of the secondary chromosomes, and
plasmid replication systems.
The replication initiation of chromosomal DNA in bacteria with a single
chromosome has been extensively studied (1). Very low-resolution electron microscopy
data showed that a large discrete assembly forms on E. coli replication origin, oriC (5-7).
A plethora of structural data is available for the replication initiator protein DnaA. The
initiator, DnaA, consists of four domains: domain I is involved in an interaction with the
helicase DnaB (8) and in self-oligomerization (9), domain II is represented by a flexible
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linker, domain III is an ATPase domain and it is also mediates protein selfoligomerization, and domain IV mediates DNA binding (8). A core DnaA fragment
(domains III and IV) from A. aeolicus crystallized as a right-handed helical filament (8).
The DnaA monomers in the filament structure contacted each other via a very extensive
protein-protein interface suggesting biological relevance of the filamentous assembly
found in the crystal. The current hypothesis states that the same kind of DnaA-DnaA
interaction is present in the assembly on the replication origin.
The current initiation model suggests that DnaA forms the same helical assembly
as observed in the crystal on the replication origin and the double-stranded DNA is
wrapped around that filament. The current model agrees with the positions of the DNAbinding domains within the filament (8). When DnaA crystals containing the protein
filament are incubated with single-stranded DNA (ssDNA) molecules, the ssDNA bound
to the protein filament. The structure of DnaA crystals soaked with ssDNA was
determined, and it revealed that the ssDNA was bound to an inner surface of the DnaA
helical filament (10). Based on these data a complete model of the complex was proposed
(Figure 1.1 A).
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Figure 1.1 A. Model of a filament formed on oriC during replication initiation (11). The
figure was extracted from (11). The left subcomplex unwinds DNA. IHF (integration host factor) binding
draws the DNA close to the single-stranded DNA binding surface of the DnaA filament, DNA unwinds and
is being fixed on the inner surface of the filament. It remains unclear whether or not the right subcomplex is
part of a uniform continuous filament as shown above. The discontinuity in oriC binding sites and their
different directionality (Figure 1.1B) do not agree with the formation of a uniform DnaA filament.
B. OriC map (11,12). OriC contains a number of DnaA binding sites. Two different groups of
sites clearly can be distinguished based on their directionality (red arrows above the sites). Strong binding
sites are shown in red and weak binding sites are shown in blue. DUE is a DNA unwinding element. The
purple arrow indicates the minimal region of oriC, which is sufficient for DNA replication initiation (13).

Even though the proposed model provides an explanation of the mechanism of
DNA replication initiation, the model still has a few caveats. For example, the left and
right halves of E. coli OriC have arrays of binding sites that have the opposite
directionality that is inconsistent with a model of a continuous filament that forms on the
entire OriC (Figure 1.1 A and B) (12).
Two halves of OriC are defined by two arrays of DnaA binding sites with
opposite directionalities, and these arrays could in fact be separate units. N. Stepankiw et
4

al. demonstrated that only the left part of the OriC is required for bacterial viability
(Figure 1.1 B, purple arrow) (13). When the right part of the OriC was completely
deleted, the E. coli bacteria was viable; however, the growth rate was significantly
affected, which demonstrates that the left part of OriC is sufficient for DNA replication
to occur. Ozaki et al. proposed that DnaA forms two different subcomplexes on OriC. A
subcomplex on the left part of OriC is required to unwind the DNA, while subcomplex of
the right part of OriC was proposed to facilitate DnaB loading (11).
Taken together, while the E. coli DNA replication initiation system is the most
studied, the model explaining mechanism of its function is still incomplete. Additional
structural information is required to explain inconsistencies in the model, and provide
detailed mechanistic explanation of the DNA replication initiation.
1.3 DNA REPLICATION INITIATION OF PLASMIDS
The DNA replication initiation system differs between the plasmid system and the
E. coli chromosomal system. Extrachromosomal DNA in the form of plasmids is present
in many species (4). Similar to chromosomal DNA, plasmid DNA must be replicated.
Plasmids replicate autonomously and control their own replication (4). In many plasmids,
the origin of replication contains several repeated binding sites for the initiator protein;
these binding sites are called iterons. The plasmid initiator protein is usually called Rep
and it is encoded within the plasmid (4). The replication origin in plasmids contains
several binding sites for the Rep initiator protein, which suggests that Rep proteins form
an oligomer on the DNA (14). The host DnaA protein is also required for initiation of
plasmid DNA replication (4); it has been suggested that this is due to the ability of
DnaA to load the helicase DnaB (4,15).
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One notable feature of plasmid replication initiators is that their function is
regulated by their oligomeric state. Rep proteins exist as head-to-head dimers in solution,
which represent an inactive form that is repressing their own transcription. Rep has to
monomerize, which is the active form, prior to binding to the replication origin (4,14-16).
In agreement with this model, mutations disrupting the dimerization interface of some
Rep proteins produce a high copy number phenotype, since a higher number of active
monomeric Rep molecules are available for the DNA replication initiation (14). Unlike
DnaA, plasmid initiators do not use ATP; however, it was proposed that ATPhydrolyzing chaperones are required to convert inactive dimeric Rep proteins into the
active monomeric form (16).
A crystal structure of the RepE initiator protein, from the F factor plasmid, bound
to its iteron DNA, demonstrated that the initiator consists of two structurally similar
DNA-binding domains. The domain similarity was not obvious from its amino acid
sequence (15). Both domains of RepE bind to specific DNA sequences within the iteron,
which results in DNA bending. It was proposed that the DNA bending introduced by
initiator proteins leads to DNA melting; however, the detailed mechanism of DNA
unwinding and the helicase loading remain unclear (15). The proposed multimeric
assembly formed by RepE on the origin of replication is shown in figure 1.2 (14,15).
Figure 1.2. Theoretical model of an assembly
formed by RepE protein on the origin DNA. The
figure was extracted from (15). Additional binding of
DNA-remodeling protein HU is required for origin
remodeling. Binding of four RepE molecules and one
HU dimer bends DNA, causing DNA supercoiling,
which leads to DNA unwinding in the AT-rich
region. The presented model does not explain the
details of DNA unwinding and the following helicase
loading, which happens with the help of the host
DnaA protein.
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Another group determined that the structure of a dimer of the N-terminal domain
of the pPS10 plasmid initiator RepA. The RepA structure revealed the dimerization
interface of the initiator and explained why the dimer is inactive; upon dimerization, the
N-terminal domain moves and loses its ability to bind DNA (14). However, the Cterminal domain of RepA retains its ability to bind DNA. The head-to-head dimer binds
to the promoter of the RepA gene using the two C-terminal domains and inhibits RepA’s
own transcription (Figure 1.3) (14)

Figure 1.3. Proposed model of RepE autoregulation. The figure was extracted from (15). As a
dimer, RepE is inactive in DNA replication initiation and is not capable of binding the iteron sequence.
However, the dimer binds to promoter DNA and represses the initiator transcription. Chaperones DnaK,
DnaJ, and GrpE activate RepE by promoting its monomerization. The RepE monomers bind to iteron
sequences with two binding sites located at the N- and C-termini of the protein.

1.4 DNA REPLICATION INITIATION IN EUKARYOTES
The main difference between DNA replication initiation in bacteria and in
eukaryotes is that, in eukaryotes, DNA replication starts at multiple origins. Unlike
bacteria, which use DnaA protein to assemble a homomultimer, eukaryotes utilize a preassembled multiprotein complex consisting of several subunits allowing for precise
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regulation; which is crucial for efficient replication of multiple eukaryotic chromosomes
once per cell cycle.
The conserved multiprotein complex that serves as a replication initiator in
eukaryotes is called the Origin Recognition Complex (ORC) (17). The ORC has six
subunits, namedORC1 through ORC6. ORC1, ORC4, and ORC5 possess an ATPbinding domain (1). ORC2 and ORC3 may have a diverged ATPase fold (1). The ORC
binds to the origin DNA and directs loading of a helicase, which in eukaryotes is called
the minichromosome maintenance (MCM) protein complex (17).
There are three common features shared by bacterial DnaA initiator and
eukaryotic initiator proteins. First, initiators form multimolecular complexes on the
replication origin, either homomeric as prokaryotic DnaA or heteromeric as eukaryotic
ORCs. Secondly, ATP binding and hydrolysis regulates the functions of these initiators;
DnaA and the ORC subunits have ATPase activity (17). Lastly, bacterial DnaA initiator
and eukaryotic initiators load a helicase onto the origin DNA. Replication initiation
mechanisms in bacteria and eukaryotes have important differences as well. The eventual
goal of an initiator protein is to load a helicase onto the origin DNA.
1.5 DNA REPLICATION INITIATION OF A SECONDARY BACTERIAL
CHROMOSOME
It is important to study the various replication initiation systems, because it will
explain the key principles of the replication initiation mechanism. The findings about a
particular replication initiation system can guide the studies of the related systems.
The present study is focused on examining the mechanism of DNA replication of
the secondary chromosome in V. cholerae. Most bacteria possess a single circular
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chromosome, but a minority of bacteria split their genome into several chromosomes.
Vibrio species possess two circular chromosomes; DNA replication initiation of these
two chromosomes is controlled by two independent systems. Replication of the
secondary chromosome requires a specific initiator protein, RctB (18). RctB was
previously shown to hydrolyze ATP (18), which would make it similar to DnaA.
However, the amino acid sequence of RctB does not display a classical ATP binding
motifs (Walker A, Walker B), and the X-ray structures of RctB domains that we describe
in this dissertation did not reveal a canonical ATP-binding fold; therefore, the conclusion
that RctB is capable of hydrolyzing ATP should be taken with caution. There is also a
report that contradicts with the proposed effect of ATP for RctB affinity to origin DNA
(19). At the same time, the secondary chromosomal DNA replication initiation system
shares similarities with the plasmid replication system. There are six direct sequence
repeats at the origin of replication of the secondary chromosome, and one DnaA binding
site, which resembles the organization of plasmid replication origin (3), (20).
The sequence and organization of the replication origin of the second
chromosome of V. cholerae was determined (Figure 1.4). The elements required for DNA
replication initiation are six directly repeated RctB binding sites, one DnaA binding site,
and an AT-rich sequence; these elements form OriCIImin (21). The 12-mer binding sites
have to be methylated in order to bind RctB (21). The chromosomal region located near
OriCIImin is called inc, and it has a regulatory function. The inc region contains several
RctB binding sites. The replication origin structure suggests that the multi-protein
complex assembly responsible for replication initiation is formed by several RctB
molecules on OriCIImin.
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Figure 1.4. Architecture of the origin of DNA replication of the secondary chromosome (oriCII)
from Vibrio cholerae. oriCII contains five distinct binding sites for the RctB initiator, named for their
length: 12-mer (pink), 11-mer (cyan), 39-mer (black), 29-mer (purple) and the rctA-39-mer (teal). The
oriCII-min segment contains six direct repeats of the 12-mer site, and is sufficient to direct replication
initiation in the presence of RctB. The other RctB binding sites are proposed to serve regulatory purposes.
The origin also contains binding sites for DnaA (light orange) and integration host factor (IHF, light
green), and an A-T rich region (white) that is the locus of the initial melting at the origin. The numbered
black bars represent the probes used for DNA binding EMSA assays.

The purpose of the present research is to provide structural insights that would
allow us to shed more light on the process of DNA replication initiation in the V.
cholerae secondary chromosomal system.
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2.1 ABSTRACT
The conserved DnaA-oriC system is used to initiate replication of primary
chromosomes throughout the bacterial kingdom; however, bacteria with multipartite
genomes evolved distinct systems to initiate replication of secondary chromosomes. In
the cholera pathogen, Vibrio cholerae, and in related species, secondary chromosome
replication requires the RctB initiator protein. Here, we show that RctB consists of four
domains. The structure of its central two domains resembles that of several plasmid
replication initiators. RctB contains at least three DNA binding winged helix turn helix
motifs, and mutations within any of these severely compromise biological activity. In the
structure, RctB adopts a head-to-head dimeric configuration that likely reflects the
arrangement in solution. Therefore, major structural reorganization likely accompanies
complex formation on the head-to-tail array of binding sites in oriCII. Our findings
support the hypothesis that the second Vibrionaceae chromosome arose from an ancestral
plasmid, and that RctB may have evolved additional regulatory features.
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2.2 INTRODUCTION
Regulated initiation is a common feature of DNA replication systems of
chromosomes. Although incompletely understood at the atomic level, studies in
Escherichia coli and other bacterial model systems have yielded great insight into this
critical process (11,12,22-27). Two molecular players play a central role in the current
model: 1) the origin of DNA replication, a site on the chromosome where DNA synthesis
begins, and 2) the initiator protein that recognizes segments of double-stranded (ds) and
single-stranded (ss) DNA within the origin (22). In E. coli, where initiation of bacterial
chromosomal replication has been extensively studied, binding of multiple DnaA initiator
proteins (~53kD) to sites within the 245 bp oriC DNA sequence leads to assembly of a
large multi-protein DNA complex (13,22,28). The DnaA-OriC complex mediates initial
melting of origin DNA within an A-T rich segment of the origin (22,29,30); the resulting
ssDNA is bound and stabilized by an oligomeric form of DnaA (10,11). Melted DNA at
the origin serves as the entry point for the replicative helicase, and additional events lead
to establishment of the replisome (31). Notably, DnaA is conserved in all bacteria (8),
suggesting that the E. coli paradigm for initiation of chromosome replication applies
throughout the bacterial kingdom. Furthermore, many elements of the bacterial paradigm
can be discerned in the more elaborate replication systems found in eukaryotes (32-34).
However, organization of the bacterial genome into the paradigmatic single
circular chromosome found in E. coli is by no means universal. For example, the
genomes of several bacterial families, including the Vibrionaceae and the related
Photobacteriacea, are distributed across more than one chromosome (35). Relatively
little is known about the factors and mechanisms that govern replication initiation of
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secondary chromosomes in bacteria with multipartite genomes. In Vibrio cholerae, the
causative agent of cholera, replication of the larger primary chromosome (chrI) is
managed by a DnaA-oriC system that closely resembles that of E. coli (3,21,36). In
contrast, replication of the smaller secondary chromosome (chrII) is managed by a
parallel system that contains unique components (3,21). Neither the chrII origin (oriCII),
nor RctB, its cognate replication initiator protein, bear any sequence similarity to
functional analogs utilized by characterized chromosome or plasmid replication systems
(35).
RctB is a highly conserved 75.3 kD protein (658 residues), which is unique to the
Vibrionaceae, and shows no detectible relationship to any other protein in the sequence
database. The first ~500 amino acids of RctB are sufficient to mediate oriCII-based
replication (35,37,38) and its C-terminal 165 residues may mediate regulatory processes
(35,37-39). The restriction of RctB to the Vibrionaceae, a large family of organisms that
includes several important human and fish pathogens, suggests it as a potential target for
discovery and design of novel selective antibacterial agents (40).
The V. cholerae oriCII DNA element spans 887 base-pairs, and is organized into
two functional domains (Figure 2.1) (39). These are: 1) a 367 bp segment (oriCII-min)
that supports RctB-based replication of plasmids containing this sequence in V. cholerae
and E. coli (21), and 2) an adjacent 520 bp segment (oriCIIinc), which exerts a negative
regulatory role on oriCII-based replication (21,39). Both oriCIIinc and oriCII-min harbor
a variety of sites, referred to as 12-mers, 11-mers, 39-mers, and 29-mers based on their
lengths, which are known to bind RctB (21,35,41-43) (Table S 2.1). OriCII-min contains
a 167 bp region that harbors six 12-mer sites, arranged with a regular spacing (10 or 11
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bps apart) in a head-to-tail manner. Thus, six copies of RctB (or a multiple thereof) are
expected to bind to oriCII-min, and associate into an oligomeric entity that should retain
the head to tail configuration of the 12-mer sites. OriCII-min also contains a single
binding site for DnaA, which is required for chrII replication (21). The remaining 190 bp
of the oriCII-min element contains an A-T rich segment, which is likely melted to initiate
replisome assembly (39), and a 29-mer RctB binding site that overlaps with the rctB
promoter (43). Thorough mutational analysis of oriCII-min revealed high sensitivity to
introduced changes (e.g. changes in the spacing between 12-mer binding sites impaired
oriCII-based replication (39)).

Figure 2.1. Architecture of the origin of DNA replication of the secondary chromosome (oriCII)
from Vibrio cholerae. oriCII contains five distinct binding sites for the RctB initiator, named for their
length: 12-mer (pink), 11-mer (cyan), 39-mer (black), 29-mer (purple) and the rctA-39-mer (teal). The
oriCII-min segment contains six direct repeats of the 12-mer site, and is sufficient to direct replication
initiation in the presence of RctB. The other RctB binding sites are proposed to serve regulatory purposes.
The origin also contains binding sites for DnaA (light orange) and integration host factor (IHF, light
green), and an A-T rich region (white) that is the locus of the initial melting at the origin. The numbered
black bars represent the probes used for DNA binding EMSA assays.

With a mass of 75.3 kDa, RctB is larger than other initiators for bacterial (DnaA:
~53 kDa), or plasmid DNA replication (RepE: 29 kDa, π: 35 kDa), implying that the
second V. cholerae initiator (DnaA is the first) may encode additional functions not found
in other initiators. To gain insights into mechanisms implemented by RctB at oriCII, we
describe biochemical and structural analyses of RctB. Our findings suggest that RctB is
comprised of four structural domains. The two central domains of RctB are structurally
related to the plasmid replication initiators RepE and π. However, RctB contains two
15

additional domains not found in the plasmid initiators, and we found that one of these
domains is also critical for the initiator to bind to oriCII and mediate replication. The
finding that the DNA binding surface of RctB is comprised of domains 1, 2, and 3
provokes reexamination of models of binding to the array of 12-mers in oriCII-min. The
head-to-head dimeric configuration seen in the RctB structure is incompatible with
binding to the head-to-tail arrangement of binding sites in oriCII; this suggests that
dissociation and/or conformational switching in RctB dimers must accompany the
initiator’s binding to oriCII.
2.3 MATERIALS AND METHODS
2.3.1 Plasmids
The wild-type RctB expression construct has been described (35). Other RctB
expression constructs were generated using conventional PCR-based cloning. Point
mutants were generated using the QuikChange® II XL site-directed mutagenesis kit
(Agilent).
The oriCII-min transformation plasmid, as well as plasmids from which the
EMSA probes corresponding to 1) the array of six 12-mer sites, 2) the inc11 site, and 3)
the inc12 site were generated have been described (39). Plasmids containing the EMSA
probes corresponding to the inc39 site, the rctA39 site, and the PrctB sites were generated
by inserting the relevant dsDNA (Table S 2.4) into the SmaI restriction of pBlueScript II
KS+.
A complete list of plasmids, primers, and EMSA probes appears in supplementary
tables 2.3, 2.4, and 2.5 respectively. The sequence of the insert in each plasmid was
verified by DNA sequencing (Genewiz).
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2.3.2 Protein biochemistry
Proteins in this study were produced using standard methods for preparing
recombinant proteins in bacteria (44). Expression plasmids for full length (35) and
designed variants (Supplementary table 2.2) included C-terminal hexahistidine affinity
tags; the full-length RctB constructs (wild type and the mutants), as well as the RctB-1499 constructs, contained an additional alanine in position 2 following the first
methionine, and additional leucine and glutamic acid residues at the C-terminus
preceding the hexahistidine affinity tag; RctB-2-124 and RctB-155-483 constructs
contained the hexahistidine affinity tag only. All the expression plasmids were grown in
E. coli BL21. Small-scale growths were performed in LB media supplemented with 50
µg/mL kanamycin. Cultures were started by addition of an overnight ‘starter’ culture
prepared from a fresh transformation at a 5% volume ratio of starter to culture volume.
Cells were cultured at 37°C until their density reached at OD600 ≈ 0.6-0.7, the culture was
cooled to approximately 20°C, and protein expression was induced by addition of 1 mM
IPTG to the culture medium. Protein expression was allowed to continue at 16°C for 1418 hours. Cells were then harvested by centrifugation and resuspended in buffer A (500
mM NaCl, 50 mM sodium phosphate (pH 8.0), 5% glycerol) at a ratio of 5 ml of buffer A
per gram of cells. Large scale growths were carried out in a fermenter as above, except
that SuperBroth (12 g/L tryptone, 24 g/L yeast extract, 2.3 g/L KH2PO4, 12.5 g/L
K2HPO4, 3.2% glycerol), supplemented with 1 mM MgCl2, and 0.1 mM CaCl2 was used
in place of LB, 100% oxygen was bubbled through the media at 0.5 – 1 L/min, and the
agitation rate was set to 450 RPM. The culture was grown at 37°C until its density
reached OD600 ≈ 2. Protein expression was induced by addition of 1 mM IPTG to the

17

media. Protein expression was allowed to proceed for 14-18 hours at 27°C. RctB proteins
substituted with selenomethionine were prepared as described (45,46).
RctB proteins used for electromobility shift assays (EMSAs) were expressed and
purified as described previously (21,47).
RctB proteins that were used for crystallization were purified using different
purification protocols with a number of chromatography steps. The first purification step
was common for all the purification protocols. The proteins were initially purified by
thawing frozen biomass cells expressing the appropriate construct into Ni buffer A (500
mM NaCl, 50 mM potassium phosphate, pH 8.0) such that a three-fold dilution was
achieved. Cell lysis was achieved by sonication. The soluble fraction was then isolated by
centrifugation and incubated with nickel-nitrilotriacetic acid (Ni-NTA) agarose
(QIAGEN) for 40 min at 4°C.
For RctB-2-124, the Ni-NTA agarose beads were washed with a set of buffer
solutions with increasing imidazole concentration containing up to 40 mM imidazole;
RctB-2-142 was then eluted by washing with 500 mM imidazole. The Ni-NTA purified
material was diluted 5-fold (to achieve a final NaCl concentration of 100 mM) with Q-SP
buffer A (20 mM Tris 7.4, 5% glycerol, 5 mM beta-mercaptoethanol), and applied to a Q
column (Q Sepharose Fast Flow, GE Healthcare) arranged inline with an SP-column (SP
Sepharose Fast Flow, GE Healthcare), both equilibrated with Q-SP buffer A. RctB was
eluted from the SP column to which it bound using a gradient from 0.1 to 2 M sodium
chloride. Fractions containing pure protein were dialyzed into the following buffer: 50
mM sodium chloride, 20 mM Tris pH 7.4, 5% glycerol, 5 mM beta-mercaptoethanol,
concentrated and either were used fresh or were flash-frozen in liquid nitrogen, and
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stored until use. The yield was approximately 18 mg per liter of culture (3 mg of protein
per 1 gram of cells).
For RctB-2-124-L48M (selenomethionine labeled), the Ni-NTA agarose beads
were washed with a set of buffer solutions with increasing imidazole concentration
containing up to 40 mM imidazole; RctB-2-124-L48M was then eluted by washing with
500 mM imidazole. The resulting Ni-NTA purified protein was concentrated, and applied
to a size-exclusion column (Superdex 200 beads, GE healthcare). Chromatography was
carried out in SEC buffer: 500 mM NaCl, 20 mM Tris pH 7.4, 5% glycerol, 5 mM betamercaptoethanol. Fractions containing pure protein were concentrated, and either were
used fresh or were flash-frozen in liquid nitrogen, and stored until use. The yield was
approximately 18 mg per liter of culture (3 mg of protein per 1 gram of cells).
For RctB-155-483 (selenomethionine labeled), the Ni-NTA agarose beads were
washed with a set of buffer solutions with increasing imidazole concentration containing
up to 60 mM imidazole, RctB-2-155-483 was then eluted with 500 mM imidazole.
Fractions containing pure protein were pooled and brought to 1.4 M ammonium sulfate
by addition of powder. Then protein was loaded onto butyl column (Macro-Prep® t-Butyl
HIC Support, BIO-RAD), and eluted with reverse gradient of ammonium sulfate
(gradient from 1.4 to 0.07 M ammonium sulfate). The fractions containing the pure
protein were pooled, concentrated, and further purified using size-exclusion
chromatography (Superdex 200 media, GE healthcare). The final buffer (SEC buffer)
contained 500 mM NaCl, 10 mM Tris pH 7.4, 5% glycerol, 5 mM beta-mercaptoethanol.
Fractions containing pure protein were concentrated, and either were used fresh or were
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flash-frozen in liquid nitrogen, and stored until use. The yield was approximately 15 mg
per liter of culture (2.5 mg of protein per 1 gram of cells).
One measure of the integrity of point mutants of RctB, in comparison to wildtype, was to assess solution properties by SEC (Figure S2.6). SEC was performed using a
21.6 ml column packed with Superdex 200 prep grade (GE Healthcare) in the following
buffer: 500 mM NaCl, 10 mM Tris-HCl pH 7.4, 5% glycerol, 5 mM 2-merceptoethanol.
Estimates of the masses of various RctB proteins were obtained by comparing elution
volumes against those by a set of molecular weight standards (GE Healthcare).
2.3.3 Electrophoretic mobility shift assay
Due to the requirement for methylated DNA (methylation at the N6 position of
the adenine residues in the sequence GATC) for RctB binding (39), it was necessary to
produce EMSA probes by excising them from methylated plasmid DNA. Probe
fragments were cloned into the pBlueScript II SK(+) vector and the constructs were
prepped from Dam(+) E. coli. The constructs were then digested with XbaI and XhoI and
treated with CIP (NEB) for 2 hours at 37 0C. The digests were separated on 1% agarose
gels and the probes were excised and extracted from the gel. The DNA was then desalted
using Illustra MicroSpin G-50 Columns (GE) and the concentration was quantitated with
a NanoDrop (ThermoFisher Scientific). The probe ends were then labeled with T4 PNK
(NEB) and a slight excess of gamma P32 ATP. The probes were separated from the
nucleotide using Illustra MicroSpin G-50 Columns (GE). The labeled probes were then
phenol-chloroform extracted and subjected to ethanol precipitation.
Binding reactions were conducted in 20 µL of 1x EMSA reaction buffer: 20mM
TrisCl pH 7.5, 1mM EDTA,150mM NaCl, 1mM MgCl2, 100 µg/mL BSA,12.5 µg/mL
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poly (dI-dC). Radiolabeled probes were added to a final concentration of 0.1 nM. The
reactions were incubated for 10 minutes at room temperature. 5 µL of 1x EMSA reaction
buffer with 50% glycerol was added to the reactions, which were then loaded onto 6%
DNA retardation gels (ThermoFisher Scientific) and run in 0.5% TBE buffer. The probes
contained binding sites embedded in a larger DNA sequence, and for the complete
sequence of the probes, please refer to table S 2.5. The gels were then dried onto filter
paper and then exposed to a Phosphor Screen and imaged with Fuji FLA-5000 imager.
Band intensities were quantified using Image Studio™ Lite software (LI-COR, Inc). The
data was fit to appropriate binding equations using KaleidaGraph 4.5.
2.3.4 Transformation Efficiency Assay
The transformation assay was performed as previously described (35,39). To
place the results of this assay on a quantitative basis, we noted that, when cells that
harbored a plasmid expressing wild-type RctB were transformed with an oriCII-min
containing plasmid, 200-300 colonies were obtained. Under these conditions, this number
of colonies was set as the maximum in our quantitative scale, thus, this assay could be
used to analyze mutant RctB proteins that have ~1% replication competence. The
standard deviation for all RctB proteins tested was 0.09 or less across the replicates.
2.3.5 Matrix-assisted Laser Desorption Time-of-Flight Mass Spectrometry
(MALDI-TOF MS) analysis
To probe for RctB domain organization, trypsin proteolysis of full-length RctB
was performed at room temperature with a trypsin:RctB ratio of 1:500 followed by
MALDI-TOF MS analysis. At various time points during digestion, 0.5 µL of the sample
was collected and mixed with 9.5 µL of matrix consisting of a saturated solution of α-
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cyano-4-hydroxycinnamic acid (CHCA) in a 1:3:2 (v/v/v) mixture of formic
acid/water/isopropanol (FWI). An aliquot of 0.5 µL of this protein-matrix solution was
spotted onto a MALDI plate precoated with an ultrathin layer of matrix (48,49). The
sample spots were washed for a few seconds with 2 µL of cold 0.1% aqueous
trifluoroacetic acid (TFA) solution. MALDI spectra were acquired in linear, delayed
extraction mode using a Spiral TOF JMS-S3000 (JEOL, Tokyo, Japan). The instrument is
equipped with a Nd:YLF laser, delivering 10-Hz pulses at 349 nm. Delayed extraction
time was set at 1 µs and acquisition was performed with a sampling rate of 2 ns. Each
MALDI spectrum corresponded to an average of 500 scans. Mass calibration was
performed using a technique of pseudo-internal calibration wherein a few shots on a
nearby calibrant spot are collected and averaged with the sample shots into a single
spectrum. The spectra were processed and analyzed using MoverZ (Proteometrics, LLC).
For characterizing protein degradation in the crystallization drop, one to two
protein crystals covered in residual mother liquor were removed from a crystallization
drop, and dissolved in the matrix solution (same as above). A 0.5 µL aliquot of the
resulting protein-matrix solution was spotted onto a MALDI plate precoated with an
ultrathin layer of matrix (48,49). The sample spots were then washed for a few seconds
with 2 µL of cold 0.1% aqueous trifluoroacetic acid (TFA) solution. MALDI spectra were
acquired and processed as detailed above.
2.3.6 Native mass spectrometry
RctB proteins samples were diluted to 10–20 µM with 10 mM Tris pH 7.4, 500
mM NaCl and subsequently buffer-exchanged into the native MS buffer (500 mM
ammonium acetate, 0.01% Tween-20) using the Zeba microspin desalting columns
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(Thermo Scientific) with a 40-kDa molecular weight cut-off. The buffer-exchanged
samples were then further diluted with the native MS buffer into the desired
concentrations ranging from 0.1 µM to 5 µM. An aliquot (2–3 µL) of the sample was
loaded into an in-house fabricated gold-coated quartz capillary and sprayed using a static
nanospray source into the Exactive Plus EMR instrument (Thermo Fisher Scientific). The
EMR was calibrated using cesium iodide. Typical native MS parameters included spray
voltage, 0.9–1.5 kV; capillary temperature, 100 °C; S-lens RF level, 200; resolving
power, 8,750 or 17,500 at m/z of 200 corresponding to 32 or 64 ms analyzer transient
duration, respectively; AGC target, 5x105; number of microscans, 5; maximum injection
time, 200 ms; injection flatapole, 8 V; interflatapole, 7 V; bent flatapole, 6 V; ultrahigh
vacuum pressure, 3–5×10−10 mbar; total number of scans, 100. The in-source
dissociation (ISD) and high energy collision dissociation (HCD) parameters were varied
accordingly. RAW files were processed manually using Thermo Xcalibur Qual Browser
(version 3.0.63).
2.3.7 Crystallization of RctB
All aspects of the crystallization of full length and shorter variants of RctB were
carried out using an automated crystallization and analysis instrument available in house.
Crystals of RctB domain 1 (1-124) were prepared using the sitting drop vapor diffusion
method by mixing 0.1, or 0.2, or 0.4 µL of the protein solution (22.4 mg/ml RctB-2-124
in 20 mM Tris pH 7.4, 50 mM sodium chloride, 5% glycerol, 5 mM 2-mercaptoethanol)
and 0.2 µL of reservoir solution (0.24 M Sodium malonate pH 7.0, 20% w/v PEG 3350).
Crystals grew within 7 days. Crystals were flash-frozen in liquid nitrogen without
additional cryoprotection for X-ray diffraction.
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Crystals of selenomethionine-substituted RctB domain 1 (1 – 124, L48M) were
grown by mixing 0.1, or 0.2, or 0.4 µL of the protein solution (20.1 mg/ml RctB-2-124L48M in 20 mM Tris pH 7.4, 500 mM sodium chloride, 5% glycerol, 5 mM 2mercaptoethanol) and 0.2 µL of reservoir solution (0.1 M Sodium HEPES pH 7.5, 20%
w/v PEG10000). Crystals grew within 7 days. In preparation of cryogenic X-ray
diffraction, crystals were transferred sequentially, over a period of 10 min, into a set of
drops that contained 5%, 10%, 15, and 20% glycerol.
Crystals of selenomethionine-substituted RctB domains 2-3 (155-483) were
prepared by mixing 0.1, or 0.2, or 0.4 µL of the protein solution (22.7 mg/ml RctB-155483 in 20 mM Tris pH 7.4, 500 mM sodium chloride, 5% glycerol, 5 mM 2mercaptoethanol) and 0.2 µL of reservoir solution (0.1 M Bis-Tris propane pH 6.5, 0.2 M
Magnesium chloride, 2% w/v PEG 8000). Crystals grew 10-14 days. In preparation of
cryogenic X-ray diffraction, crystals were transferred sequentially into a set of drops that
contained 5%, 10%, 15, and 20% glycerol over a period of 10 min.
2.3.8 X-ray data collection
Diffraction data for the RctB-2-124 crystal was recorded at the X-25 beam line at
Brookhaven National Laboratory using a wavelength of 0.979 Å. The data extended to
Bragg spacings of 2.0 Å. RctB-2-124 crystallized in space group P21, with the following
cell parameters: a = 45.84 Å, b = 52.15 Å, and c = 63.53 Å, α = 900, β = 101.50, γ = 900.
Matthews analysis indicated that the crystal had two molecules in the asymmetric unit
(Vm = 2.51 A3/Da). Diffraction data for crystals of RctB-2-124-L48M were measured at
the Stanford Synchrotron Radiation Lightsource at SLAC National Accelerator
Laboratory using a wavelength 0.9791 Å. The data extended to Bragg spacings of 2.0 Å.
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RctB-2-124-L48M crystallized in space group P1, with the following cell parameters a =
32.45 Å, b = 38.17 Å, and c = 63.04 Å, α = 97.460, β = 91.490, γ = 98.430. Matthews
analysis revealed that two molecules in the crystallographic asymmetric unit (Vm = 2.58
A3/Da). Data for the RctB-155-483 crystal was recorded at the Northeastern
Collaborative Access Team (NECAT) facility at the Advanced Photon Source at Argonne
National Laboratory using a wavelength 0.9792 Å. The data extended to Bragg spacings
of 2.6 Å. RctB-155-483 crystallized in space group R3, cell dimensions are a = 128.54 Å,
b = 128.54 Å, and c = 127.8 Å, α = 900, β = 900, γ = 1200. Matthews analysis suggested
that the two molecules resided in the asymmetric unit (Vm = 2.58 A3/Da).
2.3.9 Structure determination and refinement
Diffraction data were processed using HKL2000 software (50). Phenix (51) was
used to solve the structures of RctB-2-124-L48M and RctB-155-483 using the single
wavelength anomalous dispersion method and crystals with selenomethionine substituted
protein. The final model of RctB-2-124-L48M consists of residues 7-122 with a
crystallographic R factor of 21.46% and Rfree of 25.09%. The final model of RctB-155483 consists of residues 182-472 (with a 14-residue gap 242-255) with a crystallographic
R factor of 24.00% and Rfree of 28.38%.
The RctB-AA-2-124 structure was solved using molecular replacement (with the
RctB-2-124-L48M structure as a search model) in Phenix (51). The final model of RctB2-124 consists of residues 7-122 with a crystallographic R factor of 24.03% and Rfree of
28.04%. In all cases, initial models were improved using several rounds of model
building and refinement as implemented in Phenix (51), Coot (52) and Phenix.refine (51).
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Structural models were visualized with Coot (52) and PyMol (MacPyMOL: The PyMOL
Molecular Graphics System, v1.7.0.5 Schrödinger, LLC).
2.3.10 Crystallographic computing and structural analyses
Global structural alignments were performed using DALI on-line server (53) and
PDBefold online-server (54). Structural alignments using particular regions of a structure
were performed in Pymol (MacPyMOL: The PyMOL Molecular Graphics System,
v1.7.0.5 Schrödinger, LLC). Other calculations were carried out in the CCP4 (55) and the
Uppsala Software Factory (56,57) software suites.
2.4 RESULTS
2.4.1 RctB folds into a four-domain structure organized around two central
domains related to plasmid initiators
Our efforts to crystallize full-length RctB were thwarted by spontaneous
proteolysis in the crystallization drop. Consequently, we used limited proteolysis and
mass spectrometry (MS) to identify stable fragments more amenable for structure
determination by X-ray crystallography. Limited proteolysis of RctB resulted in rapid
release of a ~14 kDa N-terminal segment (residues 1-124, referred to as domain 1 below)
and a ~38 kDa segment (residues 155-483, referred to as domains 2-3 below) (Figs. 2.2,
S 2.1, S 2.2). Although our analysis did not yet identify a stable fragment corresponding
to the C-terminus (residues 484-658), RctB mutants deleted for these C-terminal residues
exhibit defects in binding to the inc and rctA 39-mer sequences in oriCII (35,38),
suggesting that this segment constitutes a fourth domain. Thus, RctB appears to adopt an
architecture that includes four structural domains (Fig. 2.2).
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Figure 2.2. Sequence conservation, domain architecture, and structures of the RctB initiator
protein. A) A BLAST alignment (58) consisting of 99 RctB orthologues was converted to a numerical
conservation score where equivalence of amino acid at each position was established using a normalized
BLOSUM62 matrix (59). Conservation score is plotted against the primary sequence (gray lines). Reds
dots represent positions with greater 90% sequence conservation. B) Domain architecture of RctB as
deduced from mass spectrometric analysis of proteolytic digestion products. A precise boundary for the
fourth domain of RctB could not be obtained owing to this region’s sensitivity to limited proteolysis. The
cleavage sites revealed by our analysis are depicted with scissors. C. The crystal structures of RctB domain
1 and domains 2-3 are shown in a cartoon representation. The coloring scheme employed corresponds to
that in figure 2.2B. The dotted line represents one protomer of the RctB dimer. Full-length RctB forms a
dimer, and the dimerization interface localizes to domain 2.

The structures of both the 14 kDa N-terminal (domain 1) and the 38 kDa middle
fragments (domains 2-3) were determined using X-ray crystallography (Table S 2.2).
Two crystal forms of domain 1 (one with the wild-type sequence and native
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sulfomethionine, and a second with an L48M substitution containing selenomethionine)
were used to decipher its structure; both forms contain two copies in the asymmetric unit,
but with different crystal packing arrangements. The four structures of the N-terminal
domain of RctB (molecules A and B from each of the two crystal forms) were virtually
identical (RMSD over C-alpha atoms varies from 0.23 to 0.543 Å, Fig. S 2.3). We
focused our analyses on molecule A of crystal form I (residues 2-124, L48M), as this was
the best-defined structure. RctB domain 1 consists of an array of four helices packed
against a four-stranded beta sheet (Fig. 2.2C). Comparative structural analyses using the
Dali (53) and PDBefold (54) tools revealed that RctB’s domain 1 closest structural
neighbors are a number of DNA binding proteins, including transcription factors and
replication initiators. The top hit (1Q1H) was archaeal TFIIE (a component of the core
transcriptional machinery).

Closer analysis of hits with Z-scores of 5.0 or higher

revealed a high degree of structural similarity between three alpha helices and two betasheets of RctB domain 1 (residues 42-57, 65-72, 78-91, 94-97, 111-114) and a family of
winged-helix-turn-helix motif proteins (RMSD from 1.3 to 3.0 Å, Fig. S2.4). No function
has yet been ascribed to RctB domain 1; however, these comparisons raise the possibility
(supported by findings shown below) that domain 1 binds to DNA.
The 38 kDa fragment of RctB (residues 155 – 483) crystallized as a dimer in the
asymmetric unit; the two RctB monomers are configured in a head-to-head arrangement.
The dimerization interface of RctB domains 2-3 localizes exclusively to domain 2, and is
comprised of two seven stranded beta sheets arranged in a domain swapped configuration
whereby one monomer contributes four of the seven strands to one sheet, and the
remaining three come from the second monomer; this arrangement is reversed in the
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second sheet (Fig. 2.2, Fig. S2.5). This configuration represents the most extensive
protein-protein interface in the crystal (~4300 Å2), and is likely to be functionally
significant (60). We pursue this question further below. Each 38 kDa monomer is
composed of two domains - residues 182 to 360 (henceforth domain 2) and residues 361
to 472 (henceforth domain 3). Superposition analysis revealed a small (~9°) difference
between the relative orientation of domains 2 and 3 in the two copies present in the dimer
seen in the asymmetric unit, suggesting flexibility between the two domains (Fig. S2.6).
Structural comparisons against the PDB (53,54) revealed that the 38 kDa
fragment of RctB bears significant similarity to several replication initiator proteins from
plasmid DNA replication systems, including π (2NRA, (61)), RepE (2Z90, (62), 1REP,
(15)), and RepA (1HKQ, (14)), (Z scores of between 7.7 and 9 using the DALI server).
Nearly every secondary structure element of π or RepE can be mapped on to a
corresponding element of RctB domain 2 or 3 (Fig. 2.3, Figs. S2.7, S2.8). For RepA, the
structure of only one domain of the two is available, and its secondary structure elements
correspond to RctB domain 2 (Fig. 2.3); the structure of the second domain of RepA is
not known, but it likely resembles the corresponding domain of RepE based on primary
sequence considerations (15). However, domains 2 and 3 of RctB also include some
unique structural elements (Fig. 2.3). Both RepE and RepA crystallized as dimers
(14,62), with a beta sheet arranged in a domain swapped configuration as in RctB.
However, unlike in RctB, the interfacial beta sheet for the RepE, and RepA initiators
contains five strands instead of seven; however, all – RepE, RepA and RctB – are
arranged as head-to-head dimers. The structures of these plasmid initiators, like that of
the corresponding RctB fragment, consist of two domains; both have been shown to bind
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DNA (14,15,61), suggesting that RctB domains 2 and 3 might likewise both bind to DNA
(as is confirmed below). Additional database searches using the RctB domain 2 and 3
structures individually revealed similarities with a variety of winged helix turn helix
DNA binding domains, including the archaeal and eukaryotic replication initiator
proteins Cdc6 and Orc2 proteins (Figs. S2.9, S2.10). Collectively, these analyses suggest
that RctB is a four-domain protein with a core region (domains 2 and 3) structurally
homologous to plasmid initiators, and two unique peripheral domains (domains 1 and 4),
not present in plasmid initiators.
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Figure 2.3. The structures of the central domains of RctB resemble the structures of plasmid
initiators π, RepE, and RepA. The structure of the central domains (domains 2-3) of RctB was aligned to
the π (Z-score = 9.0, RMSD = 4.9 Å), RepE (Z-score = 8.4, RMSD = 6.1 Å), and RepA (Z-score = 7.7,
RMSD = 2.9 Å) plasmid replication initiators. Depicted here is an alignment of secondary structure
elements extracted from this alignment. Elements shared by each protein are colored in cyan. Elements
unique to RctB are colored in orange, while elements present in the plasmid initiators, but not in RctB, are
colored in black. Grey circles represent regions of the various structures that were not modeled. Depiction
of RepA is limited to the one available domain. A schematic in the bottom right corner shows that RctB
middle portion (domains 2 and 3) aligns with the entire structure of π, therefore the secondary structure
alignment is shown only for domains 2-3 of RctB and structures of the plasmid initiators.
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2.4.2 RctB harbors at least three DNA binding surfaces
Mutational analyses were used to explore the possibility that the winged helix turn
helix motifs in RctB domains 1, 2, and 3 all mediate DNA binding. Comparisons against
close structural homologs bound to DNA were used to predict RctB residues likely to
contact DNA. Mutations at the selected sites were introduced into full-length RctB, and
the DNA binding capacity of mutant proteins was subsequently assessed using
electrophoretic mobility shift assays (EMSA). Additionally, the biological activity of
mutant proteins was assessed using a transformation assay in which the capacity of RctB
variants to support oriCII-min-based plasmid replication was determined (35,39).
Solution properties of mutant RctBs were tested as well; unless otherwise noted, solution
properties of the mutant proteins determined by size-exclusion chromatography did not
differ from those of the wild-type protein, indicating that substitutions did not cause
aggregation or degradation of mutant proteins (Fig. S2.11). Notably, our analyses below
do not represent a complete census of DNA binding contacts by RctB.
For RctB domain 1, comparative analyses using five distinct protein-DNA
complexes (Fig. 2.4A) suggested that Gln 83 on helix αD might be important for DNA
binding. Additionally, given their 100% conservation in RctB amino acid sequences from
diverse Vibrio species (Fig. S2.12), we hypothesized that the neighboring positively
charged residues Arg 84 and Arg 86 might also have roles in DNA binding. To evaluate
these predictions, we mutated all three positions to alanine, and measured the affinity of
the resulting triple mutant (RctB Q83A-R84A-R86A, referred to as domain 1 triple
mutant below) to six probes containing nucleotide sequences derived from oriCII: 1) the
array of six 12-mers in oriCII-min, 2) a single 12-mer sequence, 3) a single 11-mer
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sequence from the inc region, 4) the 29-mer sequence (corresponding to the RctB
promoter), 5) the inc39-mer sequence, and 6) the rctA39-mer sequence (Fig. 2.1). The
domain 1 triple mutant bound to the 6x12-mer array EMSA probe with an apparent Kd
(Kdapp) > 23,000x higher than that of wild type RctB (Figs. 2.4, S2.13). Determination of
precise Kdapp values from EMSAs using other probes was challenging owing to complex
binding curves; nevertheless, the trend we observed with probe #1 was recapitulated with
probes #2 and #3 (Figs. S2.14-2.15). However, domain 1 triple mutant binding to the 29mer, 39-mer and rctA sequences was similar to that of wild-type RctB (Figs. S2.16-2.18).
The near wild-type binding of the RctB-Q83A-R84A-R86A mutant to a subset of the
probes examined supports the idea that its structural integrity is intact. Thus the role of
domain 1 binding to DNA appears to vary depending upon the target sequence, and
domain 1 does not appear to play a critical role in binding to most regulatory sequences
outside of oriCII-min. Consistent with its severe deficiency in binding to the oriCII-min
probe, RctB domain 1 DNA-binding mutant failed to support oriCII-min-based
replication (Fig. 2.4). Taken together, these observations strongly suggest that RctB
domain 1 binds oriCII DNA, and that this function is critical for the capacity of RctB to
mediate oriCII-based replication.
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Figure 2.4. RctB has three DNA binding domains. Structural comparisons predicted the
presence of at least three distinct DNA binding domains in RctB. To evaluate these predictions, three
mutant forms of RctB were studied: A) RctB Q83A-R84A-R86A (domain 1), B) RctB K271A-K272AS274A (domain 2), and C) RctB R420A-R423A (domain 3). The top of each panel depicts a ribbon
representation (colored blue) of the predicted DNA binding domain of RctB modeled onto a DNA molecule
taken from a structural homolog bound to its DNA target. The residues selected for analysis are shown in a
ball and stick representation (colored orange).
The middle portion of each panel summarizes, in a sequence alignment format, the structural
alignment of the DNA binding domains that emerged from database searches. The residues tested in this
study are shown in orange, and labeled with orange stars. Shown in green are positions implicated in DNA
binding by other studies (15,61,63-68).
The lower portion of each panel shows the binding affinity for oriCII-min and performance in the
transformation assay by wild-type and the mutant RctB proteins.

A similar experimental approach was used to assess candidate DNA-binding
residues in RctB domains 2 and 3. The structure of RctB domain 2 was compared to
those of plasmid initiators (RepE and π) in complex with DNA, as well as to a variety of
winged-helix-turn-helix containing protein-DNA complexes. As such, domain 2 residues
Lys 271, Lys 272, Ser 274, Arg 278, Asp 279, and Arg 282 were selected for analysis.
The residues at these positions were absolutely conserved in all RctB sequences
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examined (Fig. S2.12). Two distinct triple mutant proteins, RctB-K271A-K272A-S274A
(referred to as the first domain 2 triple-mutant below) and RctB-R278A-D279A-R282A,
were prepared to test the importance of the substituted residues in RctB binding to oriCII
and in replication. The first domain 2 triple-mutant (RctB-K271A-K272A-S274A)
exhibited reduced binding affinity to all 6 oriCII derived DNA probes examined (Figs.
2.4, S2.13-2.18); e.g., its binding affinity (apparent Kd) for the 6x12-mer array probe was
reduced by ~1000-fold. A similar trend was observed with the remaining probes tested
(Fig. S2.14-2.18). Concordant with its markedly defective binding to oriCII DNA
sequences, the first domain 2 triple-mutant (RctB-K271A-K272A-S274A) was also
unable to support oriCII-based replication (Fig. 2.4). The RctB-R278A-D279A-R282A
mutant could not be produced in soluble form and was not analyzed.
Candidate DNA-binding residues in domain 3 were identified through structural
alignment of RctB to PhoB bound to its target DNA (PDB entry 2Z33); based on this
analysis, we anticipated that a number of residues, including Arg 420 and Arg 423, would
be required for DNA binding, and generated the RctB-R420A-R423A, referred to as
domain 3 double-mutant. Similar to the domain 1 triple-mutant, domain 3 double-mutant
bound to three of the six DNA probes tested differently than wild type RctB. The Kdapp of
RctB R420A-R423A binding to the 6 x12-mer array probe was ~1500-fold lower than
wild type RctB (Figs. 2.4, S2.13), and similar marked reductions in binding to individual
12-mer and 11-mer containing probes were observed (Figs. S2.14, S2.15). However,
domain 3 double-mutant binding to the 29-mer, 39-mer and rctA sequences was similar
to that of wild-type RctB (Figs. S2.16-2.18). We note that the near wild-type binding of
the domain 3 double-mutant to a subset of the probes examined supports the idea that its
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structural integrity is intact. Moreover, in contrast to the domain 1 and domain 2 mutants
(RctB Q83A-R84A-R86A and RctB-K271A-K272A-S274A, respectively) domain 3
double-mutant could support oriCII-min-based replication, albeit at reduced efficiency
compared to wild-type RctB.
Collectively, these experiments strongly suggest that at least three of the four
RctB domains are involved in contacting DNA, and, thus, that the protein contains a
much more extensive DNA binding surface than was previously appreciated (69).
Moreover, the observation that the R420A-R423A mutation only disrupts binding to a
subset of oriCII-derived sequences raises the possibility that RctB forms structurally
distinct complexes on its varied DNA targets within oriCII, and that these complexes rely
on different RctB domains to contact DNA (a summary of the DNA-binding phenotypes
of all the mutants appears in table S2.6). However, elucidation of the precise division of
labor between the three RctB DNA binding domains will require future structural and
functional analyses.
2.4.3 RctB forms a head-to-head dimer not compatible with origin binding
RctB crystallized in a head-to-head dimeric configuration. However, the head-totail array of six 12-mer sites at oriCII implies that the complex on DNA will feature an
RctB oligomer with a matched configuration. Also, RctB is known to be a dimer in
solution, but its configuration has not been described (69). To better understand RctB
oligomer dynamics, we performed mass measurements in solution, examined crystal
packing for clues on the nature of potentially distinct oligomers (dimers and higher order
oligomers), and measured the effects of disrupting the dimer seen in the crystal. First, we
analyzed the oligomeric state of full-length RctB and a panel of single and multi-domain
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RctB fragments, using native mass spectrometry (MS) (Figs. 2.5A, S2.19; figure S2.20
shows SEC data and native mass spectrometry data as well). Our findings indicate that
full-length RctB is a dimer in solution, consistent with previous reports (38,69). In
addition, only the segments containing the wild-type domains 2-3 form dimers in
solution, while all others are monomeric under the conditions tested (Figs. 2.5A, S2.19).
This finding implies that, in solution, the dimer interface is mediated by the core plasmid
initiator homology domains (domains 2-3) of RctB.
Second, we examined the packing environments associated with the two crystal
forms of domain 1 and the single crystal form of domains 2-3 for potential
physiologically relevant interfaces. Both RctB domain 1 and domains 2-3 crystallized as
dimers in the asymmetric unit. The surface area buried by the various interfaces made by
domain 1 in the crystal ranged from 30 to 1340 Å2, values at the low end for a
physiologically relevant interface (60). Thus, we conclude that the likelihood of
physiologic relevance for one of the interfaces made by domain 1 in the crystal is low.
This finding is in concert with results from native MS of wild-type domain 1 (bottom
spectrum in Fig. 2.5A).
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Figure 2.5. RctB adopts a
head-to-head
dimeric
configuration in solution.
A)
Native
mass
spectrometric analysis of the
oligomeric state of full length
and truncated constructs of
RctB, including variants that
harbored the D314P mutation
(wild-type: red, mutant:
black). Spectra for the wildtype and D314P entities are
grouped together. To the left
of each spectrum appears a
schematic, colored as in
figure
2.2B,
of
the
configuration revealed by the
analysis. B) The head-tohead dimer of RctB seen in
the crystal. The Asp314
residue on each protomer is
depicted as a red sphere.
Residues shown to be
involved in contacts to DNA
are depicted in the ball-andstick representation and
colored dark blue. The two
monomers of RctB are
colored in varying shades
(domain 2: orange, domain 3:
purple). One of the RctB
monomers is outlined with a
dashed line. C) Binding
affinity for oriCII-min and
performance
in
the
transformation assay for
wild-type and RctB-D314P.
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In contrast, the non-crystallographic dimer of RctB domains 2-3 buries an
extremely large amount of surface area (~4300 Å2), a value consistent with physiologic
relevance (60). To further explore the biological role of the RctB dimer seen in the
crystal, we substituted a proline residue (D314P) in the beta strand closest to the dimer
interface to disrupt the dimerization process and produce a monomeric form; such a
strategy was used with the RepE plasmid initiator (15). This D314P substitution was
introduced into three RctB constructs: 1) full-length (residues 1-658), 2) the smallest
fragment that is active in replication initiation (residues 1-499), and 3) the domains 2-3
construct (residues 155-483). Native MS analyses of these mutant proteins revealed that
they were all monomers under the conditions tested (Figs. 2.5A, S2.19). Furthermore,
DNA binding assays indicated that monomeric RctB-D314P bound to all six probes with
near wild-type affinity (Kdapp for the binding of the D314P mutant to oricII-min was
0.003 ± 0.006 nM versus 0.014 ± 0.01 nM for the wild-type) (Fig. 2.5C). This stands in
contrast to results from the transformation assay where the capacity of the RctB-D314P
mutant to support replication was reduced (efficiency of 0.11 versus 1 for wild-type)
(Fig. 2.5C). These findings suggest that the head-to-head dimer of RctB observed in the
crystal corresponds to the dimer revealed by native MS in solution. Additionally, the
solution configuration of the RctB dimer implies incompatibility with binding to the
head-to-tail array of 12-mer binding sites seen in oriCII. It is likely that a substantial
rearrangement will accompany formation of the RctB – origin DNA complex that
mediates replication initiation. The incompatibility of RctB head-to-head dimer with the
head-to-tail array of the 12-mer binding sites is not entirely surprising, since the same is
true for plasmid initiator systems. Plasmid initiators, which are structurally related to
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RctB, also exist as head-to-head dimers in solution, and the current model suggests
monomerization takes place prior to binding the head-to-tail sites on the replication origin
(62).
Taken together, our data shows that RctB adopts a head-to-head dimeric
configuration in solution; this arrangement resembles similarly configured dimers of the
RepA and RepE plasmid initiators (14,62). Moreover, the dimerization interface is
localized to RctB domain 2. Notably, our findings do not exclude the possibility that
other segments of RctB may play significant roles in oligomeric forms of RctB, indeed
the symmetry mismatch between the two-fold rotational symmetry of the head-to-head
dimer and the translational symmetry of the RctB binding sites at the origin make this
very likely.
2.5 DISCUSSION
In contrast to the well-studied DnaA-OriC ensemble that operates in all bacteria,
little is known about molecular mechanisms that mediate replication of secondary
chromosomes in bacteria with multipartite genomes. RctB, the conserved initiator of
chrII replication among the Vibrionaceae, lacks homologs outside of this large family of
organisms whose genomes are divided between two chromosomes. Although RctB bears
no significant sequence similarity to other proteins, we demonstrate here that the
structure of the two central domains of RctB (RctB 2-3) bears significant structural
similarity to several well-characterized plasmid initiators including RepE (from the Fplasmid), RepA (from the pPS10 plasmid) and π (from the R6K plasmid). However,
RctB is considerably larger, and contains at least 2 additional domains. Three RctB
domains contain winged helix turn helix DNA binding motifs, all of which were
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implicated in binding to oriCII, and in the initiator’s capacity to mediate oriCII-based
replication. In the crystal and in solution, RctB adopts a head-to-head dimeric
configuration mediated by interactions between residues in domain 2. However, this
arrangement is not structurally compatible with binding to the head-to-tail array of 12mer RctB binding sites in oriCII (Fig. 2.6). Additionally, we found that dimerizationdeficient RctB retained affinity to oriCII, but exhibited a greatly reduced ability to
support replication.

Figure 2.6. Incompatibility of a head-to-head dimer structure with origin binding. RctB
middle fragment structure is shown as a ribbon representation. Domains 2 are colored in different shades of
orange, domains 3 are colored in different shades of purple. The top RctB monomer is shown by dotted
line. The bottom monomer is modeled to be bound to its site on the origin, according to our findings about
the residues involved in the DNA binding and structural alignments; the two winged-helix-turn-helix
domains contact two adjacent major grooves of the DNA, the DNA binding residues are shown as red
sticks. When one of the monomers is bound to DNA, the DNA binding residues of the second monomer are
located very far away from the DNA, and they can not interact with the following binding site on the DNA.
Therefore a head-to-head RctB dimer is incompatible with origin binding not only because of the binding
site orientation (direct repeats), but also because of the molecule geometry that does not allow the second
monomer to contact the same DNA molecule.
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A segment of RctB between domains 3 and 4 has also been proposed to mediate
RctB dimerization and DNA binding (69). Our data do not support these results. Rather,
our structural, mutational, and native MS analyses provide strong evidence that DNA
binding and dimerization are instead dependent upon other regions of RctB. However, we
cannot exclude the involvement of this or other segments in weak contacts in the
expected oligomer formed on origin DNA.
The oligomeric state of plasmid initiators, which like RctB, are dimers in solution,
is thought to regulate their activity. It has been proposed that plasmid initiator dimers
dissociate into monomers prior to binding their respective replication origins, whose
arrangement of binding sites resembles that oriCII (14,15,61). It is tempting to propose
that formation of the RctB – oriCII replication initiation complex may involve
dissociation of the RctB dimer into monomers, which then seed formation of a new RctB
oligomer in the complex on origin DNA; such a complex is also predicted to form on
plasmid origins (14,15). However, our observation that disruption of the RctB dimer
diminishes, rather than enhances, biological activity as the above model predicts, and as
observed with plasmid initiators (70,71) does not, at present, allow us to rule out more
complicated protein-DNA complexes. Alternate models, such as, for example, where an
array of RctB dimers, not monomers, bind to origin DNA are possible; however, in such
models, steric constraints make it unlikely that both members of the head-to-head dimer
contact DNA. This observation has a precedent with the bacteriophage lambda cII
protein, where two protein dimers, each with two DNA-binding domains, however, only
one DNA-binding domain within each dimer binds to the major groove of the DNA
molecule (72). In addition, match in symmetry between the array of binding sites at the
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origin and the proteins that will populate these sites requires clarification. The question of
symmetry between protein configuration and DNA target sites has also been considered
with the steroid hormone receptors (73-77). Typically, these proteins bind to a pair of
target sites that exhibit head-to-head or head-to-tail configurations. With rare exception
(78), the symmetry of the DNA target matches that of the protein (73-77) (i.e. a head-totail array of DNA sites is bound by proteins that are arranged in head-to-tail manner, etc),
and we anticipate this to be true in the RctB – DNA complex. Comparisons between
RctB - DNA complexes and those made by hormone receptors to their target sites are
limited, though, because RctB binds to an array of six sites and the receptors are limited
to two sites. Indeed, it is likely that a series of novel contacts, not seen in our head-tohead dimer structure, will further stabilize the RctB oligomer. A more precise definition
of the RctB origin DNA complex must await future studies.
Although similarities between RctB and plasmid initiators were not recognized
prior to our work, previous studies have commented on similarities between iteron
plasmid and oriCII-based replication systems (20,21). Identification of the structural
similarity between RctB and plasmid initiator proteins provides greater understanding of
parallels between these systems. For example, the origins from chrII and plasmids share a
number of elements, including directly repeated initiator binding sites. However, close
examination reveals important differences, for example, the 12 bp length of the RctB
binding site is considerably shorter than the 19-22 bp length of iterons in plasmid origins.
Structures of plasmid initiators bound to DNA provide insight on likely interactions
between RctB and its binding sites on oriCII-min (Fig. 2.7). Notably, these models
suggest that only one of the three DNA binding domains on RctB can be accommodated
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on one face of the 12-mer sequence, and make sequence specific contacts in the major
groove. Thus, it seems likely that some DNA binding sites within RctB recognize
sequences other than the 12-mer, even in the context of the 6x12 array, since we have
shown that all three domains contribute to interactions made by RctB with this probe.
One possibility is that RctB also interacts with the adjacent major groove in the 10 -11 bp
spacer sequences between the 12-mers, so that the effective target size of RctB is actually
closer to that found in plasmid origins. If so, then at least one of RctB’s core DNAbinding domains is likely to lack sequence specificity in binding since the nucleotide
sequence of the spacer segments is not conserved (39). Given spatial constraints, we
postulate that domain 1 and domains 2-3 bind to opposite faces of the DNA target, where
they are presumed to also interact with the major groove (Fig. 2.7). This scheme is
compatible with the expected head-to-tail arrangement of RctB on the direct repeats in
oriCII-min, but does not rule out the possibility that there is a division of labor among the
three RctB DNA binding domains, such that some specialize in contacts to a subset of its
target sequences, as perhaps evidenced by mutational analysis of domains 1 and 3 (Figs.
2.4, S2.13-2.18). Future structural analyses of the nature of the oligomeric RctB initiator
complex on oriCII DNA are required to address these issues.
The incompatibility of the head-to-head dimeric configuration of RctB with the
directly repeated 12-mer binding sites implies that a structural reorganization must take
place prior to formation of the initiator complex on origin DNA. Indeed, this is known to
be the case for the head-to-head dimeric plasmid initiators, which do not bind to the
directly repeated binding sites within their cognate origins, unless a chaperone is
provided to promote disruption of the dimer (16). RctB, however, appears to bind to
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oriCII-min without a chaperone (though it is impossible to exclude trace amounts in our
preparations). Also, disruption of the RctB dimer into monomers does not promote DNA
binding (Fig. 2.5), as seen with the plasmid initiator RepA (16). This finding implies a
potential role for the 12-mer RctB binding site itself in the necessary structural
rearrangement. However, the precise mechanism that mediates rearrangement of the
dimer remains to be clarified. It is possible that binding of the head-to-head RctB dimer
to sites outside of the 6x12mer array in oriCII is important for RctB-mediated regulation
of initiation or of its own transcription.
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Figure 2.7. Model for the interaction of RctB with DNA. A) The 12-mer binding site is of
insufficient length to accommodate the three DNA binding domains of RctB. On the left is a ribbon
representation of the experimental structure of the π initiator (domains of π are colored in light orange and
purple) bound to its 22 bp iteron DNA target. Each domain of the π plasmid initiator binds to
approximately 10 bp of DNA. On the right is shown a schematic of the three DNA binding domains of
RctB (domain1: cyan, domain 2: orange, domain 3: purple) and its 12-mer binding site (colored in red),
drawn approximately to scale. We propose that domains of RctB (tentatively domains 1 and 2) will make
contacts to positions in a 12-mer binding site on either side of the major groove, and that domain 3
(tentatively) will make contacts to positions in the ‘spacer’ sequence between the 12-mers.
B) Linear representation of a putative head-to-tail RctB oligomer formed on the array of 12-mer
sites at oriCIImin. One of the members of the RctB oligomer is outlined with a dashed line.
C) Schematic of the putative organization of the RctB oligomer on the 12-mer array in a DNA
loop configuration to facilitate melting of the A-T-rich region of oriCIImin. This model is constructed by
analogy with that proposed for the plasmid initiator (15).
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Two basic scenarios for the evolution of multi-chromosomal bacteria have been
put forward (79,80). A single large ancestral chromosome could have split into two
chromosomes or alternatively, an ancestral strain could have acquired a plasmid, which
subsequently acquired essential genes. In this context, our discovery that the structure of
the core of RctB resembles plasmid initiator proteins lends strong support for the plasmid
acquisition scheme. However, RctB and oriCII also contain features not found in
plasmids. Notably RctB has two additional domains, one of which is critical for oriCII
binding and replication. It seems plausible that these additional domains arose during the
evolution of the Vibrionaceae, and allow for the more stringent regulatory requirements
necessary for proper chromosome maintenance.
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2.9 SUPPLEMENTARY INFORMATION
Supplementary Figures

Figure S2.1. Time-course analysis of limited proteolysis of RctB using mass spectrometry. Trypsin
digestion of full-length RctB (with 658 residues plus a C-terminal linker and hexa-histidine tag) visualized
at different time points by (A) SDS-PAGE and (B) MALDI-TOF mass spectrometry (MS). Digestion was
performed at room temperature with a trypsin:RctB ratio of 1:100 (A) or 1:500 (B). The gel bands in (A)
were assigned based on the measured masses obtained from MS analysis and labeled based on the peak
assignments on the MALDI spectra in (B). Measured mass is expressed as the average of calculated masses
across the charge state distribution. Mass deviation corresponds to the mass difference between the
measured mass and expected mass derived from the protein sequence. Peaks labeled with an asterisk (*)
refer to horse apomyoglogin used for internal MS calibration.
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Figure S2.2. Mass spectrometry of proteolysis of RctB-1-499 during crystallization. RctB degradation
products in the crystallization drop characterized by MALDI-TOF mass spectrometry (MS). The measured
mass is expressed as the average of calculated masses across the charge state distribution. Mass deviation
corresponds to the mass difference between the measured mass and expected mass derived from the protein
sequence. A set of measured masses matches the N-terminal portion of the protein (blue triangles). The
39.8 kDa mass most likely spans the middle portion of RctB (green triangle). Several masses (38 kDa, 37
kDa, and marked by **) could not be confidently matched to the amino acid sequence, as several
boundaries are possible, however, these masses most likely correspond to the central domains of RctB.
Peaks labeled with an asterisk (*) refer to horse apomyoglogin used for internal MS calibration.
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Figure S2.3. Four instances of RctB domain 1 in distinct crystal environments adopt the same
conformation. The two molecules from the RctB-2-124 crystal are colored in shades of yellow, while
those from RctB-2-124-L48M crystal are colored in shades of green. Structural alignment of the four
molecules revealed an RSMD 0.23-0.543 (C-alpha atoms). The structures of the four molecules are
virtually identical save for small variations in loop positions.
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Figure S2.4. Structural alignment of domain 1 with various DNA binding proteins using DALI (53)
and PDBefold (54). RctB domain 1 is depicted as a red ribbon. The structurally similar proteins (helixturn-helix and winged-helix proteins, a majority of which are DNA-binding proteins) are plotted as grey
ribbons. The DNA molecule from one of the hits (PDB entry = 4MTD) is shown in orange.

51

Figure S2.5. Domains 2-3 of RctB form a domain-swapped dimer. The two monomers of RctB domains
2-3 are shown in orange and green. One of the monomers is shown with a dotted line. Circled in red is the
central beta-sheet, which is formed by four beta-strands from one monomer and three beta-strands from
second monomer.
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Figure S2.6. The two monomers in the head-to-head dimer of RctB (domains 2-3) exhibit slightly
different conformations. RctB-155-483 (domains 2-3) crystallized with two molecules in the asymmetric
unit. Here, we show that they adopt slightly different conformations. Superposition of on domain 2 reveals
that relative positions of domain 3 is rotated by ~9 degrees. This variability in the observed conformations
implies existence of flexibility between the two domains.
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Figure S2.7. Structural alignment of RctB domains 2-3 and plasmid initiator π. A. A molecular
representation of the alignment of RctB domains 2-3 (domain 2 is shown in orange, domain 3 is shown in
purple) and initiator π crystallized with DNA (shown in grey). The DNA-binding helices in RctB are shown
in brighter colors (yellow in domain 2 and magenta in domain 3), the DNA-binding helices in RctB align
with DNA-binding helixes in π. B. Schematic comparison of RctB and π; the entire π molecule aligns with
RctB domains 2-3, and RctB has two additional domains that are not present in plasmid initiators.
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Figure S2.8. RctB alignment with plasmid initiators. The structure of the central domains (domains 2-3)
of RctB was aligned to the π (Z-score = 9.0, RMSD = 4.9 Å), RepE (Z-score = 8.4, RMSD = 6.1 Å), and
RepA (Z-score = 7.7, RMSD = 2.9 Å) plasmid replication initiators. Depicted here is a sequence alignment
that is based on a structural alignment. Elements shared by each protein are colored in cyan. Elements
unique to RctB are colored in orange, while elements present in the plasmid initiators, but not in RctB, are
colored in black. Black circles represent regions of the various structures that were not modeled. Depiction
of RepA is limited to the one available domain. Amino acid conservation was established using a
normalized BLOSUM62 matrix (59). Amino acids in the primary sequence are colored from white (<40%
conservation) to dark green (%100 conservation).
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Figure S2.9. Structural alignment of RctB domain 2 with various DNA binding proteins using DALI
(53) and PDBefold (54). RctB domain 2 is depicted as a red ribbon. The hits from the Dali and PDBefold
searches are plotted as thin grey ribbons. RctB domain 2 shows structural similarity to several helix-turnhelix and winged-helix proteins, a majority of which are DNA-binding proteins. The DNA molecule from
one of the hits (PDB entry = 1REP) is shown in orange.
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Figure S2.10. Structural alignment of RctB domain 3 with various DNA binding proteins using DALI
(53) and PDBefold (54). RctB domain 3 is depicted as a red ribbon. The hits from the Dali and PDBefold
searches are plotted as thin grey ribbons. Domain 3 shows structural similarity to several helix-turn-helix
and winged-helix proteins, a majority of which are DNA-binding proteins. The DNA molecule from one of
the hits (PDB entry = 4KNY) is shown in orange.
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Figure S2.11. Wild-type and DNA binding mutants of RctB exhibit similar solution properties. A)
Size-exclusion profiles for Ni-NTA purified RctB WT and RctB mutants. The pooled peak protein fractions
are shaded in light blue. B) Pooled fractions from panel A were concentrated to 1 mg/ml and reanalyzed by
size-exclusion chromatography. In all cases, wild-type and mutant RctB proteins elute as a single peak with
a retention volume of 11.6-11.7 ml.
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Figure S2.12. Sequence conservation and secondary structure of domains 1, 2, and 3 of RctB. A
BLAST alignment (58) consisting of 99 RctB orthologs was converted to a numerical conservation score
where equivalence of amino acids at each position was established using a normalized BLOSUM62 matrix
(59). Amino acids in the primary sequence are colored from white (< 40% conservation) to dark green
(%100 conservation). The secondary structure of RctB domains 1, 2, and 3 – from separate structure
determinations – is plotted against the primary sequence. Grey circles represent positions in the
experimental structures that could be modeled.
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Figure S2.13. Electrophoretic mobility shift assays of wild-type and mutant RctB proteins with a
probe containing the array of six 12-mer sites from oricIImin. The protein (wild-type or mutant) is
indicated for each panel (A-E). In all cases, the EMSA gel appears on the left, and a fit of the data to a
binding curve appears on the right. The protein concentration for each gel are as follows: lane 1: no protein,
lane 2: 24 fM, lane 3: 98 fM, lane 4: 390 fM, lane 5: 1.6 pM, lane 6: 6.3 pM, lane 7: 25 pM, lane 8: 100
pM, lane 9: 400 pM, lane 10: 1.6 nM, lane 11: 6.4 nM, lane 12: 25 nM, lane 13: 102 nM, lane 14: 410 nM,
lane 15: 1.6 mM. The red arrows indicate lanes where the fraction of bound DNA brackets the point of half
occupancy. The RctB-Q83A-R84A-R86A (B), RctB-K271A-K272A-S274A (C) and RctB-R420A-R423A
(D) mutants demonstrate reduced binding to the array of six 12-mer sites compared to wild type RctB (A)
and RctB-D314P (E). By default the following equation was used to fit the data (F = A*x/(Kdapp+x) + B,
where F – fraction bound, x – protein concentration, and Kdapp is an apparent dissociation constant; in
experiments where the total DNA concentration (0.1 nM) is comparable to the Kdapp, the following
quadratic equation was used: F = A*(((Prottot + DNAtot +Kdapp) – ((((Prottot + DNAtot +Kdapp)^2) – 4*
Prottot* DNAtot)^0.5))/(2* DNAtot)) + B, where Prottot is total protein concentration, DNAtot is total DNA
concentration (and it is equal to 0.1 nM), Kdapp is an apparent dissociation constant. Error bars represent
the standard deviation between two independent experiments.
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Figure S2.14. Electrophoretic mobility shift assays of wild-type and mutant RctB proteins with a
probe containing a single 12-mer site. The protein concentration values for each gel are identical to those
in figure S2.13. For the experiments in figures S2.12 to S2.16, dissociation constants could not be
extracted from these experiments due to complex binding interactions. To enable a meaningful comparison
between gels, we selected lanes in the gel where DNA occupancy was 0.15 (green arrow) and 0.5 (red
arrow) as handles for comparison. By this measure, we observe an occupancy of 0.15 at 6.3 picomolar
concentration for wild type RctB (panel A), which reaches 0.5 at 25 nanomolar protein. By contrast, the
pattern of these two occupancies exhibited by the RctB-Q83A-R84A-R86A (B), RctB-K271A-K272AS274A (C) and RctB-R420A-R423A (D) mutants differ markedly and we conclude that the above mutants
are defective in DNA binding. For RctB-D314P (E), the overall pattern of binding was only slightly altered
in comparison to wild-type, and we conclude that the monomeric RctB-D314P mutant binds DNA similar
to wild type.
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Figure S2.15. Electrophoretic mobility shift assays of wild-type and mutant RctB proteins with a
probe containing a single 11-mer site. The protein concentration values for each gel are identical to those
in figure S13. For these experiments apparent binding constants could not be extracted due to complex
binding interactions. To enable a meaningful comparison between gels, we selected lanes in the gel where
DNA occupancy was 0.15 (green arrow) or 0.5 (red arrow) as handles for comparison. By this measure, we
observe an occupancy of 0.15 at 6.3 picomolar concentration for wild type RctB (panel A), which reaches
0.5 at 6.4 nanomolar protein. By contrast, the pattern of these two occupancies exhibited by the RctBQ83A-R84A-R86A (B), RctB-K271A-K272A-S274A (C) and RctB-R420A-R423A (D) mutants differ
markedly, thus, we conclude that the above mutants are defective in DNA binding. For RctB-D314P (E),
the overall pattern of binding was only slightly altered in comparison to wild-type, and we conclude that
the monomeric RctB-D314P mutant binds DNA similar to wild type.
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Figure S2.16. Electrophoretic mobility shift assays of wild-type and mutant RctB proteins with a
probe containing a single 29-mer site. The protein concentration values for each gel are identical to those
in figure S2.13. For these experiments apparent binding constants could not be extracted due to complex
binding interactions. To enable a meaningful comparison between gels, we selected lanes in the gel where
DNA occupancy was 0.15 (green arrow) and 0.5 (red arrow) as handles for comparison. By this measure,
we observe an occupancy of 0.15 at 1.6 nanomolar concentration for wild type RctB (panel A), which
reaches 0.5 at 25 nanomolar protein. We conclude that in these experiments wild type RctB (panel A),
RctB-Q83A-R84A-R86A (B), RctB-R420A-R423A (D) and RctB-D314P (E) share similar DNA binding
patterns, but binding by RctB-K271A-K272A-S274A (C) was reduced.
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Figure S2.17. Electrophoretic mobility shift assays of wild-type and mutant RctB proteins with a
probe containing a single 39-mer site. The protein concentration values for each gel are identical to those
in figure S2.13. For these experiments apparent binding constants could not be extracted due to complex
binding interactions. To enable a meaningful comparison between gels, we selected lanes in the gel where
DNA occupancy was 0.15 (green arrow) and 0.5 (red arrow) as handles for comparison. By this measure,
we observe an occupancy of 0.15 at 1.6 nanomolar concentration for wild type RctB (panel A), which
reaches 0.5 at 25 nanomolar protein. We conclude that in these experiments wild type RctB (panel A),
RctB-Q83A-R84A-R86A (B), RctB-R420A-R423A (D) and RctB-D314P (E) share similar DNA binding
patterns, but binding by RctB-K271A-K272A-S274A (C) was reduced.
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Figure S2.18. Electrophoretic mobility shift assays of wild-type and mutant RctB proteins with a
probe containing a single rctA39-mer site. The protein concentration values for each gel are identical to
those in figure S2.13. For these experiments apparent binding constants could not be extracted due to
complex binding interactions. To enable a meaningful comparison between gels, we selected lanes in the
gel where DNA occupancy was 0.15 (green arrow) and 0.5 (red arrow) as handles for comparison. By this
measure, we observe an occupancy of 0.15 at 6.4 nanomolar concentration for wild type RctB (panel A),
which reaches 0.5 at 102 nanomolar protein. We conclude that in these experiments wild type RctB (panel
A), RctB-Q83A-R84A-R86A (B), RctB-R420A-R423A (D) and RctB-D314P (E) share similar DNA
binding patterns, but binding by RctB-K271A-K272A-S274A (C) was reduced.
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Figure S2.19. Assembly states of the wildtype and mutant versions of RctB as characterized by native
MS. The wild-type RctB and all wild-type segments containing domain 2 are dimeric. In contrast, mutant
versions harboring a single residue substitution in the dimerization interface of domain 2 (D314P) are
monomeric. The assembly states observed for each sample did not change across the concentration range
studied. The measured mass of the dominant peak series is shown as the average of all the mass values
obtained from the charge state distribution (n≥4). The mass accuracy is indicated in parenthesis.
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Figure
S2.20.
Size
exclusion profiles of
various
RctB
constructs (wild type
and
the
D314P
mutation) and native
mass
spectrometry
data for RctB-D314P.
RctB-155-483 and RctB155-483-D314P
elute
from SEC as a dimer and
monomer, respectively
(A), RctB-1-499 and
RctB-1-499-D314P elute
from SEC as a dimer and
monomer, respectively
(B); however full-length
RctB and full length
RctB-D314P elute at
essentially the same
position on SEC; this is
unexpected as the wildtype is a dimer and the
D314P mutant is a
monomer. (C). Three
different preparations of
RctB-D314P full-length
(from three different
growths) were examined
by
native
mass
spectrometry, and all of
them were found to be
predominantly
monomers
(D,
E).
Native
mass
spectrometry reports on
the mass, and is,
therefore, a true measure
of the oligomerization
state. We do not know
why the full-length
wildtype and monomer
mutant of RctB share the
same elution profile on
SEC. We suspect that
non-specific interactions
with the chromatography
beads, or the overall shape differs between wild-type and mutant. These factors could explain the
unexpected migration profile.
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Supplementary Tables
Supplementary table 2.1. Sequences of the various RctB binding sites. The adenine
residues that require methylation are shown in bold and are enlarged.
Binding site name
12-mer

Sequence

11-mer

ATGATCAAGAG
TTGGAACTATAGTGATATTACGGTAAGTG
GCGGAAGCATGTAAATTCATTATCAATTTACGGTCGATG
GCGGAACGATTAAACCGAGCCACTAAGTTACGGTGAATG

29-mer (PrctB)
39-mer
rctA39mer

ATGATCATGCTT
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Supplementary table 2.2. Data collection, phasing and refinement statistics for SAD
(SeMet) structures and the structure obtained with molecular replacement
RctB-AA2-124-L48M
(SAD)

RctB-AA2-124
(molecular replacement)

RctB-AA155-483
(SAD)

P1

P 21

R3

32.45, 38.17, 63.04
97.46, 91.49, 98.43

45.837, 52.15, 63.533
90, 101.537, 90

128.54, 128.54, 127.8
90, 90, 120

Wavelength
Resolution (Å)

0.9791 (peak)
2.0 (CC1/2 = 0.712)

0.979
2.0 (CC1/2 = 0.878)

0.9792 (peak)
2.6 (CC1/2 = 0.506)

Highest resolution shell

2.03 – 2.00

2.03-2.00

2.64 – 2.60

Rsym all data (in highest
resolution shell)

0.049 (0.496)

0.057 (0.282)

0.053 (0.828)

<I / sigI> all data (in
highest resolution shell)

26.42 (2.44)

17.05 (2.42)

21.7 (0.88)

Completeness (%) all
data (in highest
resolution shell)

94.3 (96.9)

84.3 (64.6)

99.4 (99.0)

Average redundancy all
data (in highest
resolution shell)

2.0 (2.0)

1.6 (1.4)

2.9 (2.7)

2.0
18162
0.214/0.247

2.0
15588
0.227/0.266

2.6
23743
0.235/0.277

1846
152

1846
64

4578
31

43.57
47.31

49.48
46.54

91.05
63.57

0.003
0.58

0.006
0.76

0.002
0.546

99.56%
0%
5UBD
10.15785/SBGRID/413

98.68%
0%
5UBE
10.15785/SBGRID/412

96.7%
0%
5UBF
10.15785/SBGRID/414

Data collection
Space group
Cell dimensions
a, b, c (Å)
a, b, g (°)

Refinement
Resolution (Å)
No. reflections
Rwork / Rfree
No. atoms
Protein
Water
B-factors
Protein
Water
R.m.s deviations
Bond lengths (Å)
Bond angles (°)
Ramachandran plot
statistics (MolProbity)
Ramachandran favored
Outliers
PDB code
SBGrid DataBank ID

By default the resolution was determined using CC0.5 > 0.5 criteria. In case of RctB-AA2-124-L48M and RctB-AA2124 at the chosen resolution limit CC0.5 is much greater than 0.5, however, the incompleteness of data beyond the
chosen resolution due to the detector position had to be taken into account as well. For RctB-AA2-124 completeness in
highest resolution shell is 64.6 %, and completeness goes above 90% in 2.44 - 2.37 shell. For RctB-AA2-124-L48M
completeness in highest resolution shell is above 90%. In the RctB-155-483 structure, density for residues 242-255 is
missing and density for residues 450-457 is defined poorly. The Ramachandran plot for these regions should be
interpreted with caution.
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Supplementary table 2.3. Plasmids.
Plasmid name

Vector

Purpose

pET-RctB-wt

Vector
insert
RctB-WTfull-lengthC-His

pET28b

Protein
expression

(35)

pYB355

RctB-1-500

pET28b

Protein
expression

(39)

pNO012

RctB-AA2124-C-His

pET24a

Protein
expression

pNO017

RctB-AA2124-L48MC-His
RctBAA155483-C-His
RctBD314P-CHis
RctBAA155483-D314PC-His
RctB-AA1499-D314PC-His
RctBK271AK272AS274A-CHis
RctBQ83AR84AR86A-CHis
RctBR278AD279AR282A-CHis
RctBR420AR423A-CHis

pET24a

Protein
expression

pET24a

Protein
expression

pET28b

pNO011

pNO026

pNO035

pNO044

pET-RctB-FLK271K272S274

pET-RctB-FLQ83R84R86

pET-RctB-FLR278D279R282

pNO046

Primers

Citation

RctB-S2-L124-forward,
RctB-S2-L124-C-HisSTOP-r
RN-L48M-forward,
RN-L48M-r

This paper

This paper

Protein
expression

RctB-L155-R483forward, RctB-L155R483-C-His-STOP-r
RctB-D314P-for, RctBD314P-rev

pET24a

Protein
expression

RctB-D314P-for, RctBD314P-rev

This paper

pET24a

Protein
expression

RctB-D314P-for, RctBD314P-rev

This paper

pET28b

Protein
expression

K271A-K272A-S274Afor, K271A-K272AS274A-rev

This paper

pET28b

Protein
expression

Q83A-R84A-R86Aforward, Q83A-R84AR86A-reverse

This paper

pET28b

Protein
expression

RB- R278A-D279AR282A-for, RBR278A-D279A-R282Arev

This paper

pET28b

Protein
expression

RB-420-423-for, RB420-423-rev

This paper
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This paper

This paper

pYB285

RctB wt

pGZ1119EH

RctB
expression

pGZ-RctB-FLK271K272S274

RctBK271AK272AS274A
RctBQ83AR84AR86A

pGZ1119EH

RctB
expression

pET-RctB-5’-pGZEcoRI-fz, pET-RctB-3’pGZ-EcoRI-fz

This paper

pGZ1119EH

RctB
expression

pET-RctB-5’-pGZEcoRI-fz, pET-RctB-3’pGZ-EcoRI-fz

This paper

pGZ-RctB-FLR420R423

RctBR420AR423A

pGZ1119EH

RctB
expression

pET-RctB-5’-pGZEcoRI-fz, pET-RctB-3’pGZ-EcoRI-fz

This paper

pGZ-RctB-FLD314

RctBD314P

pGZ1119EH

RctB
expression

pET-RctB-5’-pGZEcoRI-fz, pET-RctB-3’pGZ-EcoRI-fz

This paper

pBS-12x6

DnaA box
and 6 12mers from
oriCII

pBlueScript
II KS+

EMSA probe

(39)

pBS-inc11

11-mer
from inc

pBlueScript
II KS+

EMSA probe

(39)

pBS-inc12

12-mer
from inc

pBlueScript
II KS+

EMSA probe

(39)

pBS-inc39

39-mer
from inc

pBlueScript
II KS+

EMSA probe

inc39-mer-For, inc39mer-Rev

This paper

pBS-rctA39

39-mer
from rctA

pBlueScript
II KS+

EMSA probe

rctA39-mer-For,
rctA39-mer-Rev

This paper

pBS-PrctB

29-mer
from PrctB

pBlueScript
II KS+

EMSA probe

PrctB-For, PrctB-Rev

This paper

pYB199-pseudooriCII-wt

DnaA box,
6 12-mers,
and AT-rich
region from
oriCII

pYB199

Transformation
Assay

pGZ-RctB-FLQ83R84R86
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(35)

(39)

Supplementary table 2.4. Primers.
Primer name
RctB-S2-L124-forward
RctB-S2-L124-C-His-STOP-r
RN-L48M-forward
RN-L48M-r
RctB-L155-R483-forward
RctB-L155-R483-C-His-STOP-r
RctB-D314P-for
RctB-D314P-rev
RB-420-423-for
RB-420-423-rev
Q83A-R84A-R86A-forward
Q83A-R84A-R86A-reverse
K271A-K272A-S274A-for
K271A-K272A-S274A-rev
RB- R278A-D279A-R282A-for
RB- R278A-D279A-R282A-rev
pET-RctB-5’-pGZ-EcoRI-fz
pET-RctB-3’-pGZ-EcoRI-fz
inc39-mer-For
inc39-mer-Rev
rctA39-mer-For
rctA39-mer-Rev
PrctB-For

PrctB-Rev

Sequence
GATCATATGAGCTCAGAAGAAAAACGATTGATCAAATTGC
GTGGGATCCTTAATGATGATGATGATGATGGAGTACCGAG
ATCAATTGGTTGGGG
CAAGAAAAGCATTGTTGAACTTATGAATGTGATCTCACTG
C
GCAGTGAGATCAGATTCATAAGTTCAACAATGCTTTTCGT
G
GATCATATGTTACTGCATGAGCATGGTTTAAATACACC
GTGGGATCCTTAATGATGATGATGATGATGGCGTTTACCC
GCGTTGGTGG
CGCTAAAAAGCGAAAACGAGGGCTTTTAAAGCCTTCTGGC
GCCAGAAGGCTTTAAAAGCCCTCGTTTTCGCTTTTTAGCG
CTTCCCTTCGGAGAGACGAGCAAGTTCGGCGATCAGATCC
ATAGAAAAC
GTTTTCTATGGATCTGATCGCCGAACTTGCTCGTCTCTCCG
AAGGGAAG
CAACAGCTACCGCTGCTGCCAAGGCCGCCTGGATGGCTGC
ACGCG
CGCGTGCAGCCATCCAGGCGGCCTTGGCAGCAGCGGTAGC
TGTTG
ATCGAGTCACGTGCCGGGCCGGCGTCTGCTGCGCCACGTA
AAGAGAGAATGTC
GACATTCTCTCTTTACGTGGCGCAGCAGACGCCGGCCCGG
CACGTGACTCGAT
GATCAATACTGTCAGCGATCGAGGCAGCTGCCGGGCCGCT
GTCT
AGACAGCGGCCCGGCAGCTGCCTCGATCGCTGACAGTATT
GATC
ATAACAATTTCACACAGGAAACAGAATTCGCCCTTGATAC
GGATCTAACCATGGCCAGCTCAGAAGAAAAACG
GATCCCCGGGTACCGAGCTCGAATTCTTAGGCTCCAGCGG
CCATCTC
AGGCCTGTAAATCGTCGCGGAAGCATGTAAATTCATTATC
AATTTACGGTCGATGTCAGGCAGAGCATATG
CATATGCTCTGCCTGACATCGACCGTAAATTGATAATGAA
TTTACATGCTTCCGCGACGATTTACAGGCCT
AGGCCTGCGAGCCGTAAGCGGAACGATTAAACCGAGCCA
CTAAGTTACGGTGAATGCCATTCTGATTGACATATG
CATATGTCAATCAGAATGGCATTCACCGTAACTTAGTGGC
TCGGTTTAATCGTTCCGCTTACGGCTCGCAGGCCT
AGGCCTTTTAAAAACAACAAATTTTTCTTTATTTATGATCT
CTTTTTCTTTATTCTCTTGGAACTATAGTGATATTACGGTA
AGTGTGATACGGATCTAACCATGCATATG
CATATGCATGGTTAGATCCGTATCACACTTACCGTAATATC
ACTATAGTTCCAAGAGAATAAAGAAAAAGAGATCATAAA
TAAAGAAAAATTTGTTGTTTTTAAAAGGCCT
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Supplementary table 2.5. EMSA probes.
EMSA probe
12x6

inc11

inc12

inc39

rctA39

PrctB

DNA sequence
CTCGAGGTCATCCACTCAGGTTGTGGATAAACTGTGTGAG
CACCTTGATCATGCTTAGAAGCTTACGTTGATCATTGATTC
TGTTGACTGATGATCATGCTTAGAGGAACAAATGATCATG
CTTTCGATCTTGTATTGATCATGGTTTCCATCGATACATGA
TCATGCTTCTGAATGGCTTAAAATAATCTCTTTTAATTACA
ATAAATTAGAACTAGGGCTGCAGGAATTCGATATCAAGCT
TATCGATACCGTCGACCTCGAGGGGGGGCCCGGTACCCAG
CTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCGCT
TCTAGAACTAGTGGATCCCCCGTAGCATATGGATGACATC
AAGATAGGTCGTTGTATCTCCTTCCTCTCGTACTCTCATGA
CCACGGAAAGATGATCAAGAGAGGATGATTTCTTGGCCAT
ATCGCAATGAATACTTGTGACTTGTGCTTCCAGGCCTCCTT
GGGCTGCAGGAATTCGATATCAAGCTTATCGATACCGTCG
ACCTCGAG
TCTAGAACTAGTGGATCCCCCTAACCATATGCAATGAATA
CTTGTGACTTGTGCTTCCAATTGACATCTTCAGCGCCATAT
TGCGCTGGCCAAGGTGACGGAGCGGGATTACGAAAGCAT
GATCATGGCTGTTGTTCTGTTTATCTTGTTTTGACTGAGAC
TTGTTAGGATAGACGGTTTTTCATCACTGACTAGCCAAAG
CCTTACTCAGGCCTCTCAGGGCTGCAGGAATTCGATATCA
AGCTTATCGATACCGTCGACCTCGAG
TCTAGAACTAGTGGATCCCCCAGGCCTGTAAATCGTCGCG
GAAGCATGTAAATTCATTATCAATTTACGGTCGATGTCAG
GCAGAGCATATGGGGCTGCAGGAATTCGATATCAAGCTTA
TCGATACCGTCGACCTCGAG
TCTAGAACTAGTGGATCCCCCCATATGTCAATCAGAATGG
CATTCACCGTAACTTAGTGGCTCGGTTTAATCGTTCCGCTT
ACGGCTCGCAGGCCTGGGCTGCAGGAATTCGATATCAAGC
TTATCGATACCGTCGACCTCGAG
TCTAGAACTAGTGGATCCCCCAGGCCTTTTAAAAACAACA
AATTTTTCTTTATTTATGATCTCTTTTTCTTTATTCTCTTGGA
ACTATAGTGATATTACGGTAAGTGTGATACGGATCTAACC
ATGCATATGGGGCTGCAGGAATTCGATATCAAGCTTATCG
ATACCGTCGACCTCGAGGGGGG
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Supplementary table 2.6. Summary of the DNA-binding phenotypes for the mutants
discussed in the study.
Mutant

Domain 1 DNA
binding mutant
(Q83A-R84AR86A)
Domain 2 DNA
binding mutant
(K271A-K272AS274A)
Domain 3 DNA
binding mutant
(R420A-R423A)
Dimerization
mutant (D314P)

12x6

12-mer

Binding site
11-mer
39-mer

dramatically
reduced
binding

dramatically
reduced
binding

dramatically
reduced
binding

dramatically
reduced
binding

reduced
binding

dramatically
reduced
binding
Mutation
does not
significantly
affect
binding.
Monomeric
mutant can
efficiently
bind the
OriCII.

dramatically
reduced
binding
about wildtype binding
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rctA39mer

about
wild-type
binding

29-mer
(PrctB)
about
wild-type
binding

reduced
binding

reduced
binding

reduced
binding

reduced
binding

dramatically
reduced
binding
about wildtype binding

about
wild-type
binding
about
wild-type
binding

about
wild-type
binding
about
wild-type
binding

about wildtype
binding
about wildtype
binding

about wildtype
binding

CHAPTER 3 – RCTB – ORICII INTERACTIONS
3.1 ABSTRACT
In the previous chapter, we reported the first structure of the secondary
chromosomal initiator protein. Based on the RctB structure a model of a complete
macromolecular assembly that RctB forms on the origin DNA was developed and
discussed in the previous chapter. However, there are unresolved questions, such as what
is the structure of the fourth domain of RctB and what role it plays in the complex
assembly and the regulation of RctB function. In this chapter, we discuss the x-ray
structure of the fourth domain of RctB and the attempts to explain the functions of the
domain four. Revealing of the function of the C-terminal domain of RctB would allow
for detailed understanding of various RctB – OriCII interactions.
3.2 INTRODUCTION
Despite a lot of effort to elucidate the process of bacterial DNA replication
initiation, the mechanism of this process at the molecular level remains largely unclear.
Bacteria possess several types of DNA molecules: such as the primary chromosome,
plasmids, and in minority of cases secondary chromosome(s). The studies of the
Escherichia coli’s chromosomal system provided key insights into the mechanism of
DNA replication initiation. The key players in the process of DNA replication initiation
are: the specific DNA fragment, called origin of DNA replication (OriC in E. coli
chromosome), and the initiator protein (DnaA in E. coli chromosomal system). Structures
of the initiator proteins for the primary bacterial chromosome (DnaA) and a number of
plasmid initiators (Rep proteins) were solved. There is an abundance of biochemical data
was available for these two systems: the primary chromosome and the plasmid replication
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systems. The origin of replication of the secondary chromosome in Vibrio cholerae
(called OriCII) was studied in detail (39). However, the structure of the initiator protein
for the secondary bacterial chromosome was not available until a recent study was
published. The study reported the structures of the three main domains of RctB, the
initiator protein for the secondary chromosome in V. cholerae (81).
RctB protein is unique in its amino acid sequence; however the RctB structure
demonstrated that the core RctB fragment (domains 2-3) shares high degree of structural
similarity with plasmid replication initiators. The RctB structure provided insights into
the mode of RctB-DNA interactions and allowed for the development of a hypothesis
regarding the structure of the RctB-OriCII complex. However, the hypothesis about the
structure that RctB forms on the replication origin still has some details that require better
understanding. The two important unresolved questions are: whether RctB monomerizes
prior to binding to the OriCII and the function of the C-terminal domain of RctB. It was
reported previously that the C-terminal fragment of RctB is expected to be involved in
binding of the regulatory RctB binding sites (35,37). On the other hand comparisons
between the binding pattern of the full-length RctB and the truncated RctB construct that
is missing the C-terminal fragment (RctB-1-499), suggest that the C-terminal fragment of
RctB plays a role in protein-protein interactions resulting in cooperativity in DNA
binding (39). It is important to understand the complex role of the C-terminal fragment of
RctB to have a complete understanding of the replication initiation machinery in the
secondary bacterial chromosome.
We demonstrated that the monomeric RctB-D314P has higher affinity to a probe
with six binding sites from the OriCII than the wild-type RctB, which suggests that there
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is an additional event that should take place before the wild-type RctB can bind the
origin, presumably the monomerization step. We also demonstrated that all the
intermediate complexes that RctB wild-type and RctB-D314P form on the DNA
molecules with three or six binding sites have the same exact electrophoretic mobility
when they are ran on the same gel. These results suggest that the same intermediate
species are being formed regardless of the original oligomeric state of RctB.
Our native mass-spectrometry data suggest that domain four of RctB is involved
in protein-protein interactions, which agrees with our SAXS data and EMSA data. In
order to investigate the function of domain four in detail, the X-ray structure of the
domain four of RctB was determined. Based on the crystal structure a series of mutants
was designed for the future analysis of the function of the C-terminal domain of RctB.
3.3 MATERIALS AND METHODS
3.3.1 Plasmids
The wild-type RctB expression construct has been described previously (35).
Other RctB expression constructs were described (81). Plasmid for the expression of
RctB domain 4 (528-658) was generated using conventional PCR-based cloning.
Plasmids for the expression of RctB mutants were cloned using Quick Change XL II kit
(Agilent) (Supplementary table 2).
Plasmids containing the EMSA probes, corresponding to the 12x3 and 12x6
binding sites were generated by subcloning the relevant dsDNA (Supplementary table 4)
into the pUC18 vector.
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A complete list of plasmids, primers, and EMSA probes appears in supplementary
tables 2, 3, and 4 respectively. The sequence of the insert in each plasmid was verified by
DNA sequencing (Genewiz).
3.3.2 Protein biochemistry
Proteins in this study were produced using standard methods for preparing
recombinant proteins in bacteria (44). Expression plasmids for full length (35) and
designed variants ((81), supplementary table 2) included C-terminal hexahistidine affinity
tags; the full-length RctB constructs (wild type and the mutants), as well as the RctB-1499 constructs, contained an additional alanine in position 2 following the first
methionine, and additional leucine and glutamic acid residues at the C-terminus
preceding the hexahistidine affinity tag; RctB-528-658 construct contained the
hexahistidine affinity tag only. All the expression plasmids were grown in E. coli BL21.
Small-scale growths were performed in LB media supplemented with 50 µg/mL
kanamycin. Cultures were started by addition of an overnight ‘starter’ culture prepared
from a fresh transformation at a 5% volume ratio of starter to culture volume. Cells were
cultured at 37°C until their density reached at OD600 ≈ 0.6-0.7, the culture was cooled to
approximately 20°C, and protein expression was induced by addition of 1 mM IPTG to
the culture medium. Protein expression was allowed to continue at 16°C for 14-18 hours.
Cells were then harvested by centrifugation and resuspended in buffer A (500 mM NaCl,
50 mM sodium phosphate (pH 8.0), 5% glycerol) at a ratio of 5 ml of buffer A per gram
of cells. Large scale growths were carried out in a fermenter as above, except that
SuperBroth (12 g/L tryptone, 24 g/L yeast extract, 2.3 g/L KH2PO4, 12.5 g/L K2HPO4,
3.2% glycerol), supplemented with 1 mM MgCl2, and 0.1 mM CaCl2 was used in place of
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LB, 100% oxygen was bubbled through the media at 0.5 – 1 L/min, and the agitation rate
was set to 450 RPM. The culture was grown at 37°C until its density reached OD600 ≈ 2.
Protein expression was induced by addition of 1 mM IPTG to the media. Protein
expression was allowed to proceed for 14-18 hours at 27°C. RctB-528-658 protein
substituted with selenomethionine was prepared as described (45,46).
RctB-528-658 proteins (native and selenomethionine-substituted) that were used
for crystallization were purified using two chromatography steps. The proteins were
initially purified by thawing frozen biomass cells expressing the appropriate construct
into Ni buffer A (500 mM NaCl, 50 mM potassium phosphate, pH 8.0) such that a threefold dilution was achieved. Cell lysis was achieved by sonication. The soluble fraction
was then isolated by centrifugation and incubated with nickel-nitrilotriacetic acid (NiNTA) agarose (QIAGEN) for 40 min at 4°C. Then Ni-NTA agarose beads were washed
with a set of buffer solutions with increasing imidazole concentration containing up to 50
mM imidazole; proteins were then eluted by washing with 500 mM imidazole. The
resulting Ni-NTA purified protein was concentrated, and applied to a size-exclusion
column (Superdex 200 beads, GE healthcare). Chromatography was carried out in SEC
buffer: 150 mM NaCl, 20 mM Tris pH 7.4, 5% glycerol, 5 mM beta-mercaptoethanol.
Fractions containing pure protein were concentrated, and either were used fresh or were
flash-frozen in liquid nitrogen, and stored until use. The yield was approximately 10 mg
per liter of culture.
RctB proteins used for electromobility shift assays (EMSAs) were expressed and
purified as described above, except that after the Ni-NTA purification proteins were
directly dialyzed in the following buffer: 500 mM NaCl, 10 mM Tris pH 7.4, 5%
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glycerol, 5 mM beta-mercaptoethanol. After dialysis proteins were concentrated and
flash-frozen in liquid nitrogen.
3.3.3 Limited proteolysis of the C-terminal region of RctB
The limited proteolysis reactions were conducted in cleavage buffer: 20 mM
HEPES, pH 7.5, 50 mM KCl, 10 mM MgSO4. The following proteases were used:
proteinase K, subtilisin, chymotrypsin, elastase. The cleavage reactions were conducted
on ice using 1:100 and 1:1000 ratios of protease to protein, and at different time points a
sample of the reaction was mixed with the loading dye (4x SDS sample buffer with 10
mM EDTA and 10 mM PMSF) and flash-frozen in liquid nitrogen. The products were
analyzed using 15% SDS-PAGE gels.
3.3.4 Secondary structure prediction for the C-terminal region of RctB
The secondary structure prediction for the C-terminal region of RctB was
obtained using Jpred and Psipred on-line servers.
3.3.5 Electrophoretic mobility shift assay
The short EMSA probes that were non-methylated were obtained by annealing
single-stranded oligos purchased from IDT. However, the methylated probes
(methylation at the N6 position of the adenine residues in the sequence GATC is required
for RctB binding to the “12-mer” sites (39)), it was necessary to produce EMSA probes
by excising them from methylated plasmid DNA. Probe fragments were cloned into the
pUC18 vector and the constructs were prepped from Dam(+) E. coli. The constructs were
then digested with EcoRV and treated with CIP (NEB) for 2 hours at 37 0C. The digests
were separated on 3% agarose gels and the probes were excised and extracted from the
gel. The DNA was then purified using Illustra MicroSpin G-50 Columns (GE) and the
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concentration was quantitated with a NanoDrop (ThermoFisher Scientific). The probe
ends were then labeled with T4 PNK (NEB) and a slight excess of gamma P32 ATP. The
probes were separated from the nucleotide using Illustra MicroSpin G-50 Columns (GE).
Binding reactions were conducted in 20 µL of 1x EMSA reaction buffer: 20mM
TrisCl pH 8.0, 1mM EDTA,150mM NaCl, 1mM MgCl2, 5% glycerol, 100 µg/mL BSA,
10 µg/mL poly (dI-dC). Radiolabeled probes were added to a final concentration of 0.2
nM. The reactions were incubated for 10 minutes at room temperature. Reactions were
then loaded onto 6% DNA retardation gels and run in 0.5% TBE buffer. The gels were
then dried onto filter paper and then exposed to a Phosphor Screen and imaged with
Typhoon FLA-9500 imager. Band intensities were quantified using Image Studio™ Lite
software (LI-COR, Inc). The data was fit to appropriate binding equations using
KaleidaGraph 4.5.
3.3.6 Crystallization the C-terminal domain of RctB
The crystallization of the C-terminal domain of RctB was carried out using an
automated crystallization and analysis instrument available in house. Native crystals of
RctB domain 4 (528-658) were prepared using the sitting drop vapor diffusion method by
mixing 0.1, or 0.2, or 0.4 µL of the protein solution (23.4 mg/ml RctB-528-658 in 20 mM
Tris pH 7.4, 150 mM sodium chloride, 5% glycerol, 5 mM 2-mercaptoethanol) and 0.2
µL of reservoir solution (0.2 M Ammonium acetate, 0.1 M TRIS-HCl pH 8.5, 15%
Isopropanol). Crystals grew within 7 days. In preparation of cryogenic X-ray diffraction,
crystals were transferred sequentially, over a period of 10 min, into two drops that
contained 5% and 20% glycerol (the original protein holding solution plus 5 or 20%
glycerol).

82

Crystals of selenomethionine-substituted RctB domain 4 (528-658) were prepared
using the sitting drop vapor diffusion method by mixing 0.1, or 0.2, or 0.4 µL of the
protein solution (23.3 mg/ml RctB-528-658 in 20 mM Tris pH 7.4, 150 mM sodium
chloride, 5% glycerol, 5 mM 2-mercaptoethanol) and 0.2 µL of reservoir solution (0.1 M
Sodium HEPES pH 7.5, 0.15 M magnesium chloride, 19% w/v PEG400). In preparation
of cryogenic X-ray diffraction, crystals were transferred sequentially, over a period of 10
min, into two drops that contained 5% and 20% glycerol (the original protein holding
solution plus 5 or 20% glycerol).
3.3.7 X-ray data collection
Diffraction data for the RctB-528-658 native crystal were recorded at the Stanford
Synchrotron Radiation Lightsource at SLAC National Accelerator Laboratory using a
wavelength 1.195 Å. The data extended to Bragg spacings of 2.0 Å. Native RctB-528658 crystallized in space group P 1 21 1 (P 21), cell dimensions are a = 43.58 Å, b = 64.24
Å, and c = 47.42 Å, α = 900, β = 90.8160, γ = 900. According to Matthews analysis the
crystal contains two molecules in the crystallographic asymmetric unit (Vm = 2.11
A3/Da).
Diffraction data for the RctB-528-658 selenomethionine-substituted crystal were
recorded at the Stanford Synchrotron Radiation Lightsource at SLAC National
Accelerator Laboratory using a wavelength 0.9791 Å. The data extended to Bragg
spacings of 1.5 Å. Native RctB-528-658 crystallized in space group P31 1 2, cell
dimensions are a = 46.77 Å, b = 46.77 Å, and c = 118.84 Å, α = 900, β = 900, γ = 1200.
According to Matthews analysis the crystal contains one molecule in the asymmetric unit
(Vm = 2.4 A3/Da).
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3.3.8 Structure determination and refinement
Diffraction data were processed using HKL2000 software (50). Phenix (51) was
used to solve the structure of selenomethionine-substituted RctB domain 4 (528-658)
using the single wavelength anomalous dispersion method and crystals with
selenomethionine

substituted

protein.

The

final

model

of

RctB-528-658

(selenomethionine-substituted protein crystals) consists of residues 528-655 with a
crystallographic R factor of 19.8% and Rfree of 22.0%.
The RctB-528-658 (native protein crystals) structure was solved using molecular
replacement (with the RctB-528-658 (obtained using selenomethionine-substituted
protein crystals) structure as a search model) in Phenix (51). The final model of RctB528-658 (native protein crystals) consists of residues 528-655 with a crystallographic R
factor of 18.1% and Rfree of 22.0%. The initial model was improved using several
rounds of refinement as implemented in Coot (52) and Phenix.refine (51). Structural
models were visualized with Coot (52) and PyMol (MacPyMOL: The PyMOL Molecular
Graphics System, v1.7.0.5 Schrödinger, LLC).
3.3.9 Crystallographic computing and structural analyses
Global structural alignments were performed using DALI on-line server (53).
Other calculations were carried out in the CCP4 (55).
3.3.10 SAXS data analysis
SAXS data analysis was performed using ATSAS software (82). Primus program
was used for Guinier analysis. Gnom program was used for evaluation of the particle
distance distribution function p(r). DAMMIF program was used to generate molecular
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envelopes (83). CORAL program was used to fit the available domain X-ray structures
into the scattering pattern of the complete particle (82).
3.3.11 Native mass spectrometry
RctB proteins samples were diluted to 10–20 µM with 10 mM Tris pH 7.4, 500
mM NaCl and subsequently buffer-exchanged into the native MS buffer (500 mM
ammonium acetate, 0.01% Tween-20) using the Zeba microspin desalting columns
(Thermo Scientific) with a 40-kDa molecular weight cut-off. The buffer-exchanged
samples were then further diluted and mixed with DNA probes in order to reach final
solution containing: 3 or 4 µM protein, 1 µM DNA, 250 mM sodium chloride, 0.01%
Tween-20, 1mM magnesium chloride.
An aliquot (2–3 µL) of the sample was loaded into an in-house fabricated goldcoated quartz capillary and sprayed using a static nanospray source into the Exactive Plus
EMR instrument (Thermo Fisher Scientific). The data collection parameters and the data
processing software used as described previously (81).
3.4 RESULTS
3.4.1 RCTB MONOMERIZATION
There are two proposed possible models for the complex formation on the OriCII.
According to the first model, the RctB dimer monomerizes and the resulting monomers
assemble a complex with six RctB molecules bound in a head-to-tail manner to the six
binding sites on the OriCII. The other model suggests that the RctB dimer stays intact
and the dimers form the final assembly on the replication origin, such that each dimer
binds to the 12-mer site only with one of its RctB molecules forming the dimer, while the
other molecule does not contact the DNA. It is important to determine which of these two
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possible models is the correct one in order to obtain a deeper understanding of the RctBOriCII initiation system.
One of the obstacles that complicated the analysis of the RctB-OriCIImin
complexes was that in prior EMSA analysis, the DNA probes always contained a vast
excess of DNA on either side of the binding sites; this could have been a reason why
RctB demonstrated non-standard binding behavior, and it was not clear how many RctB
molecules bind the DNA. In this study, we used short EMSA probes that contained only
the six RctB binding sites (or three binding sites respectively) from OriCII and no extra
DNA. The difference between the binding affinity of the monomeric RctB and the wild
type RctB was not clear when the longer probe was used; the difference in the apparent
Kd was on the order of magnitude of the error. Surprisingly, when the shorter probe
containing just the six RctB binding sites was used it resulted in an overall lower affinity
of binding; however, it became obvious that monomeric RctB mutants (RctB-D314P and
truncated RctB-1-499-D314P) bind this probe tighter than RctB wild type (and truncated
dimeric RctB-1-499 respectively) (Figures 3.1 and 3.2, supplementary figure S 3.1). The
observation that the monomeric RctB-D314P has higher affinity to the DNA probes with
binding sites from the OriCII than wild-type RctB suggests that there is an additional step
that the dimeric RctB has to undergo prior to binding the OriCII, which presumably is the
dissociation of the RctB dimers to monomers.
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Figure 3.1. Comparison of the affinities of the dimeric RctB-1-499-DNA interaction and
monomeric RctB-1-499-D314P-DNA interaction. A and B. Comparison of RctB-1-499 and RctB-1-499D314P binding to DNA probe with three binding sites. On each gel the left side shows titration of RctB-1499, and the right side shows titration of the RctB-1-499-D314P, that allows comparison of electrophoretic
mobility of the resulting complexes on gel B. RctB-1-499-D314P starts binding at lower concentrations and
forms full complex at lower concentrations. Kdapp for RctB-1-499 is 520 nM, Kdapp for RctB-1-499D314P is 25 nM. The monomeric mutant binds about 20-fold tighter. C and D. Comparison of RctB-1-499
and RctB-1-499-D314P binding to DNA probe with six binding sites. On each gel the left side shows
titration of RctB-1-499, and the right side shows titration of the RctB-1-499-D314P. RctB-1-499-D314P
starts binding at lower concentrations and forms full complex at lower concentrations. Kdapp for RctB-1499 is 200 nM, Kdapp for RctB-1-499-D314P is 12 nM. The monomeric mutant binds about 17-fold
tighter.
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Figure 3.2. Comparison between electrophoretic mobility of complexes formed by dimeric
and monomeric RctB constructs. Note that in all the experiments the protein concentration range for the
dimeric and monomeric proteins is different, because monomeric proteins have higher affinity to the DNA
probes. A. RctB-1-499 and RctB-1-499-D314P form three distinct complexes when binding to the DNA
probe with three RctB binding sites. The corresponding complexes have the same electrophoretic mobility.
B. RctB-1-499 and RctB-1-499-D314P form six different complexes when binding to DNA probe with six
binding sites. Electrophoretic mobility of the corresponding complexes formed by RctB-1-499 and RctB-1499-D314P is the same. C. RctB and RctB-D314P form three distinct complexes, and a species staying in
the well, when binding to the DNA probe with three RctB binding sites. Electrophoretic mobility of the
corresponding complexes formed by RctB and RctB-D314P is the same. D. RctB and RctB-D314P bind a
DNA probe with six binding sites with high degree of cooperativity and the intermediate complexes can
hardly be observed.

Moreover, when complexes formed by wild type RctB and monomeric RctB (the
intermediate species and the fully occupied probe) were run on the same exact retardation
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gel, the resulting species had the same mobility (Figure 3.2). This suggests that RctB
behaves similarly to plasmid initiators, and we could not observe it using the longer
probe. The results of the EMSAs with the shorter probe could potentially be explained in
the following way: monomeric RctB starts binding at lower concentrations than the wild
type RctB, because monomers are already pre-formed, and the intermediate species
formed by the RctB wild type and the monomeric mutant are in fact the same since they
have the same mobility. To prove that this explanation is indeed correct, additional
experiments are required. However, the aforementioned EMSAs are an important
indicator that the hypothesis about RctB monomerization is likely to be true.
In order to test whether in the context of a larger complex one RctB molecule
binds one RctB binding site, we reconstructed in vitro a RctB-DNA complex with 3
binding sites. The DNA probe with three binding sites was chosen because three is an
odd number and if we observe three RctB molecules on DNA, this will allow easier
interpretation of the experimental results, i.e. the observed masses. Using a short probe
containing three RctB binding sites we were able to reconstruct a complex with a
monomeric RctB mutant and detect it via native mass spectrometry. In the case of RctB499-D314P, when 1 uM of DNA (probe with three sites) was mixed with 4 uM of RctB
(1.33 fold protein excess), we observed 2 species: 2RctB-499-D314P:1DNA and 3RctB499-D314P:1DNA. The 3RctB-499-D314P:1DNA complex was slowly falling apart
during electrospray. When full-length RctB-D314P was used with the same ratio (excess
protein), 2 species were observed: 3RctB-D314P:1DNA (major species) and 4RctBD314P:1DNA (Figure 3.3). It demonstrates that monomeric RctB-D314P can form a
complex with 3 proteins on the DNA with 3 binding sites, and also that the complex with
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the full-length RctB (that has the fourth domain unlike RctB-1-499-D314P) is more
stable. Indeed, the fourth protein molecule can bind to the complex, presumably getting
attached to the small excess of DNA, being held together by protein-protein interactions
between domains four of adjacent molecules.

Figure 3.3. Native mass spectrometry analysis of in vitro reconstructed protein-DNA
complexes. A. RctB-1-499-D314P when mixed at slight excess with a DNA probe with three binding sites
forms 2 species: 3RctB-1-499-D314P:1DNA and 2RctB-1-499-D314P:1DNA. B. RctB-D314P when
mixed at slight excess with a DNA probe with three binding sites forms 2 species: 3RctB-1-499D314P:1DNA and 4RctB-1-499-D314P:1DNA. RctB-D314P when mixed at a 1 to 1 ratio with a DNA
probe with three binding sites forms 2 species: 3RctB-1-499-D314P:1DNA and 2RctB-1-499D314P:1DNA.
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However, we were not able to reconstitute the 3RctB:1DNA complex using RctB
wild type; we only observed the 2RctB:1DNA species that presumably was an original
dimer binding DNA. This can be explained as follows: native mass spectrometry requires
relatively high concentrations (relative to the concentrations used in EMSAs for
example), and close to 1:1 ratios of the components, a large excess of either one would
not produce data that can be interpreted. Therefore, the conditions that are required for
native mass spectrometry analysis might be incompatible with the conditions required for
RctB wild type monomerization; these exact conditions remain unclear. Attempts of
native mass spectrometry experiments with the DNA probe containing six binding sites
did not produce readable spectra, most likely because there was a mixture of species
(6RctB-D314P-1DNA, 5RctB-D314P-1DNA, 4RctB-D314P-1DNA, etc) that could not
be resolved. Even though native mass spectrometry experiments were not as insightful as
we hoped, the experiments with the three-site DNA probe and RctB-1-499-D314P
suggest that the full complex that we observed in EMSAs (with the same probe and
protein) is 3proteins-1DNA. Accordingly, the two intermediate species are 1protein1DNA, and 2proteins-1DNA respectively, which helps the interpretation of the EMSA
gels (Figure 3.2).
3.4.2 THE FUNCTION OF THE C-TERMINAL DOMAIN
Truncated RctB that is missing the C-terminal domain is capable of replication;
however, there are two possible roles that the C-terminal domain could play. It was
proposed that the C-terminal domain of RctB is important for binding to alternative DNA
sites, apart from the 12-mers in the inc region (regulatory region) within OriCII (35,37).
This suggests that the C-terminal domain could be involved in the regulation of DNA
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replication via mediating RctB binding to regulatory binding sites. The other potential
role can be proposed based on the comparison of the binding patterns of wild type RctB
and truncated RctB (missing the C-terminal domain) to the OriCIImin probe. Wild type
RctB binds the OriCIImin probe with a high degree of cooperativity; which can be
concluded since no intermediate complexes are observed in previous EMSAs.
Furthermore, only two outcomes are observed: no binding or the complete final complex.
In contrast, the truncated RctB, missing the C-terminal domain had all the intermediate
complexes present (39). The previous comparison suggests that the C-terminal domain of
RctB can form protein-protein interactions between the adjacent RctB molecules
positioned on OriCII, resulting in stabilization of the complex and the cooperative
binding that is observed in the case of wild-type RctB.
In order to fill the gap in understanding the role of the C-terminal domain of RctB
we first set out to determine the border of the stable domain 4 construct. Previously
trypsin digestion and limited proteolysis in the crystallization drop revealed the borders
of domains 1 and 2-3 of RctB; however, under these conditions, domain 4 was digested
and the domain border could not be identified. Secondary structure prediction software
helped to identify a potentially long flexible linker in the beginning of the expected Cterminal domain of RctB (Figure 3.4). Then, limited proteolysis of an available RctB Cterminal construct (RctB-485-658-C-His, which failed to crystallize) was performed with
different proteases, and the results of chymotrypsin digestion appeared to be consistent
with a prediction of a 21 amino acid linker (Figure 3.5). Therefore, based on the
secondary structure prediction and limited proteolysis information, the new construct for
RctB C-terminal domain was cloned: RctB-528-658.
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Figure 3.4. Secondary structure prediction for the C-terminal portion of RctB (RctB-485658).
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Figure 3.5. Limited proteolysis of the C-terminal portion of RctB (RctB-485-658). Limited proteolysis
experiments with chymotrypsin and subtilisin demonstrated that upon proteolysis stable species with the
mass of 15-18 kDa were formed.

This protein construct easily crystallized and its structure was solved using X-ray
crystallography (Figure 3.6). Two crystal forms were obtained, one had one molecule in
an asymmetric unit and the other had two molecules in an asymmetric unit. All the crystal
contacts in both molecules were inspected in order to determine the buried surface area
for each interaction. Only one dimerization interface has a buried surface area that could
potentially be biologically relevant (1815 Å2, a value that could suffice for a biologically
relevant interaction). However, this is a head-to-head dimerization, which is not
consistent with a proposed head-to-tail interaction that would connect all the six proteins
on the origin. It is also possible that the relevant protein-protein interaction interface was
not captured in the available crystal forms. The C-terminal domain structure was
structurally aligned to all the other structures form the PDB database, however, the Zsores for all the alignments are rather low (the highest Z-score is 4.9). Since analysis of
the buried surface areas and the structural alignments did not provide a ready answer
about the function of RctB’s C-terminal domain, it was necessary to design a set of Cterminal domain mutants. Each mutant would have a 1-3 surface amino acid substitution,
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with an aim to disrupt any possible protein-protein interactions, and/or affect potential
protein-DNA interactions. The residues that were chosen for mutational analysis are
shown in figure 3.7. The mutants are listed in supplementary table S 3.2 (expression
vectors pNO053 through pNO072).

Figure 3.6. Domain composition of RctB, and the structure of the C-terminal domain of
RctB. A. The domain composition of RctB. Scissors indicate regions susceptible to limited proteolysis.
Numbers indicate domain borders. B. X-ray structure of the C-terminal domain of RctB (RctB-528-658).
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Figure 3.7. The amino acids chosen for mutational analysis. A. A cartoon representation of the
X-ray structure of the C-terminal domain of RctB (RctB-528-658). B. A ribbon representation of the RctB528-658 structure, the residues that were chosen for mutational analysis are shown as magenta sticks.

The notion that the fourth domain of RctB plays a role in protein-protein
interactions is being supported by our mass spectrometry data. Indeed we observed that if
the truncated RctB-1-499-D314P was used in a reaction with the three-site probe, a
limited number of complexes were observed: 3proteins:1DNA and 2proteins:1DNA.
However, if the full-length RctB-D314P was used we observed 3proteins:1DNA and
4proteins:1DNA, where the fourth RctB molecule was probably held in part by proteinprotein interactions between domains four of adjacent RctB molecules (Figure 3.3).
Moreover, analysis of our SAXS data shows that for the truncated RctB
constructs missing the fourth domain (RctB-1-499 and RctB-1-499-D314P), the Rg and
molecular weight estimation are consistent on the entire range of concentrations used.
The independence of Rg and the estimated molecular weight suggests that the samples
are mono-disperse at the entire concentration range. However, analysis of the data for the
full-length RctB constructs (RctB wild-type and RctB-D314P) showed that at
concentrations above approximately 2 mg/ml, the Rg and the calculated molecular weight
started to increase with concentration. This increase is likely to be caused by some sort of
association of the protein molecules (Table 3.1, raw SAXS data are presented in
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supplementary figure S 3.2). Guinier analysis did not detect significant aggregation of the
full-length RctB constructs; however, there are probably some additional oligomers
formed that affected the Rg and MW estimation. The effect of increasing Rg estimation is
influenced by the presence of the fourth domain; this suggests that the C-terminal domain
is involved in protein-protein interactions that promote the association. The conclusion
derived from the SAXS data that the C-terminal domain is likely to be involved in
protein-protein interactions is consistent with the native mass-spectrometry data and the
EMSA data. The SAXS experiments have to be reproduced in order to establish that the
observed phenomena are taking place consistently.
The SAXS experiments allowed for reconstruction of the overall shape of the fulllength RctB molecule; however, the linkers that are missing in the available X-ray
structures are rather large, which leaves room for uncertainty of the reconstruction. This
reconstruction is shown in figure 3.8. The fit of the reconstruction into the molecular
envelope generated using DAMMIF software is presented in supplementary figure S 3.3.
The reconstruction emphasizes how large and complex the RctB molecule is; this
complexity and size reinforces the idea of RctB’s multifunctional role being regulated in
a myriad of forms. The SAXS data has to be reproduced in order to be more confident in
the reconstruction.
All the mutants that were designed in order to test our hypothesis about the
function of the fourth domain of RctB have been cloned, expressed and purified. Two of
the proteins (RctB-H572R-A573G-S576A and RctB-W590A-R592A-N595A) have
demonstrated severe degradation during the purification process; therefore they were
abandoned for future studies.
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Table 3.1. Rg and molecular weight estimations from SAXS data for RctB wild-type, RctB-1499, RctB-D314P, RctB-1-499-D314P.
Construct

Concentration
(mg/mL)

Rg
(Å)

RctB wild-type

0.4
0.8
1.7
2
3.4
5
6.7

47.9
46.5
47.9
49.1
50.0
53.0
56.0

Molecular
weight
(kDa)
182.4
182.3
180.1
180.4
187.0
213.3
217.8

RctB-1-499

0.8
1
1.7
2
3.3
5
6.6
13.2
0.6
1
1.2
2
2.4
4.8
5
9.6

42.7
43.6
42.9
43.8
43.4
43.8
43.9
46.0
48.9
58.0
52.7
59.0
54.6
59.2
64.2
70.4

117.8
125.0
118.9
125.0
124.6
133.9
134.0
135.6
123.9
137.1
130.9
154.8
146.9
171.3
179.1
215.3

0.3

32.6

55.6

0.5
1
1.1
2
2.2
4.3

33.3
33.8
33.2
34.0
33.2
35.5

48.5
57.4
57.0
58.0
56.9
59.0

RctB-D314P* the
sample
had
insufficient purity
and the experiment
has to be repeated.
The
presented
results are for the
reference.

RctB-1-499D314P
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Notes

At concentrations less than or equal to 2
mg/ml, Rg and molecular weight
estimations are consistent. The molecular
weight estimation is close to the expected
one – 152.8 kDa. However, at higher
concentrations Rg and MW start
increasing. For all the samples SD for Rg
is 3.1 Å. The highest MW estimation
differs from the expected by 43%.
For all the samples SD for Rg is 0.99 Å.
SD is 6.9 kDa for the MW estimation.
Molecular weight estimation is close to the
expected one 117.1 kDa. The highest MW
estimation differs from the expected by
16%.

The RctB-D314P protein used in this
experiment did not have sufficient purity,
therefore these results have to be taken
with caution, and presented just for a
reference. This experiment will be
repeated in the near future. However, the
present experiment also demonstrated a
tendency where the Rg and molecular
weight estimation tend to rise dramatically
with concentration.
For all the samples SD for Rg is 0.87 Å.
SD is 3.3 kDa for the MW estimation.
Molecular weight estimation is close to the
expected one - 58.6 kDa. The most
different MW estimation differs from the
expected by 17%.

Figure 3.8. The model of the full-length RctB based on SAXS data using the CORAL
program. The available X-ray structures were modeled to reconstruct the full-length RctB molecule based
on the small-angle X-ray scattering data. Chi squared for the fit is 2.9843. The linkers missing in the X-ray
structures are modeled as spheres. Domains are color-coded as follows: domain 1 – cyan, domain 2 –
purple, domain 3 – orange, domain 4 – green.

As mentioned earlier, in the previous study all the EMSA probes contained RctB
binding sites embedded in a large piece of extra DNA. In this study, we were aiming to
use the shortest probes possible. Using the shorter probe containing six RctB binding
sites “12-mers”, resulted in an overall lower binding affinity; however, this allowed us to
make very important observations. To study the interaction of RctB and the regulatory
binding site, the 39-mer, we aimed to use the same approach – shorten the probe.
Unfortunately, EMSAs with a double-stranded oligo containing just the 39 base pairs (the
shortest probe possible) did not demonstrate any significant binding. It remains unclear
why shortening of the EMSA probes results in a significant modification of the binding
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affinity. This question is yet to be resolved. In spite of this in our studies we are planning
to return to the original 39-mer probe, that contained the 39-mer binding site embedded
in the longer DNA molecule. Using this probe, we are planning to test how all the
purified eighteen mutants will compare to wild-type RctB in binding to the 39-mer site.
All the eighteen mutants will be compared to the RctB wild-type in binding to the probe
with the six 12-mers as well, to assess the effect of these mutations on the protein-protein
interactions between RctB molecules.
3.5 DISCUSSION
The analysis of the available data allowed us to develop a hypothesis about the
function of the C-terminal domain of RctB. The two proposed roles of domain four of
RctB are: protein-protein interactions stabilizing the RctB-OriCII complex, and the
involvement in binding of the regulatory RctB binding sites, such as 39-mer. Our native
mass-spectrometry, EMSA and SAXS data together suggest the role of RctB in proteinprotein interactions is likely to be true. We solved the structure of the domain four of
RctB and designed, cloned, expressed and purified mutants that will allow us to test the
hypothesis described above. This work is currently in progress.
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3.6 SUPPLEMENTARY DATA

Figure S 3.1. Comparison of the binding affinities of the RctB-1-499 and RctB-1-499-D314P to
DNA probes. In both cases the binding affinity of the monomeric RctB-1-499-D314P is higher than the
affinity of the dimeric RctB-1-499.
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Figure S 3.2. Raw SAXS data. The graphs Log(I) vs q are presented for the four proteins. For
each protein there are several curves, which correspond to measurements for the samples with different
concentrations.
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Figure S 3.3. The RctB model fit into the molecular envelope. The reconstruction obtained
using the CORAL program was manually fit into the envelope generated using DAMMIF program. There
is a moderate level of agreement between the structure and the envelope.
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Supplementary table 3.1. Data collection, phasing and refinement statistics for SAD (SeMet)
structure and the structure obtained with molecular replacement.
RctB-528-658
(SAD)

RctB-528-658
(molecular replacement)

P31 1 2

P 21

46.77, 46.77, 118.84
90, 90, 120

43.58, 64.24, 47.42
90, 90.816, 90

Wavelength
Resolution (Å)

0.9791 (peak)
1.5 (CC1/2 = 0.946)

1.195
2.0 (CC1/2 = 0.971)

Highest resolution shell

1.53 – 1.50

2.03-2.00

Rsym all data (in highest
resolution shell)

0.034 (0.184)

0.05 (0.105)

<I / sigI> all data (in
highest resolution shell)

39.3 (6.74)

41.49 (11)

Completeness (%) all
data (in highest
resolution shell)

96.8 (89.4)

81.7 (31.3)

Average redundancy all
data (in highest
resolution shell)

3.0 (2.9)

3.8 (2.4)

1.5
23711
0.198/0.220

2.0
14386
0.181/0.220

999
219

2038
249

19.29
32.69

23.82
30.30

0.004
0.68

0.002
0.43

95.97%
0%
XXXX

96.43%
0%
YYYY

Data collection
Space group
Cell dimensions
a, b, c (Å)
a, b, g (°)

Refinement
Resolution (Å)
No. reflections
Rwork / Rfree
No. atoms
Protein
Water
B-factors
Protein
Water
R.m.s deviations
Bond lengths (Å)
Bond angles (°)
Ramachandran plot
statistics (MolProbity)
Ramachandran favored
Outliers
PDB code
SBGrid DataBank ID

By default the resolution was determined using CC0.5 > 0.5 criteria; however, for both structures, at the chosen
resolution limit CC0.5 is much greater than 0.5, but the incompleteness of data beyond the chosen resolution due to the
detector position had to be taken into account as well. For RctB-528-658 (molecular replacement) completeness in
highest resolution shell is 31.3%, and completeness goes above 90% in 2.44 - 2.37 shell.
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Supplementary table 3.2. Plasmids.
Plasmid name

Vector insert

Vector

Purpose

pET-RctB-wt

RctB-WTfull-lengthC-His

pET28b

Protein expression

(35)

pYB355

RctB-1-499C-His

pET28b

Protein expression

(39)

pNO026

RctBD314P-CHis

pET28b

Protein expression

(81)

pNO044

RctB-AA1499-D314PC-His

pET28b

Protein expression

(81)

pET28b-RctB-485658

RctB-485658-C-His

pET28b

Protein expression

Waldor lab

pNO052

RctB-528658

pET24a

Protein expression

RctB-528-658-forward,
RctB-528-658-C-HisSTOP-r

This paper

pNO053-pET28bVcRctB-D640RH642A-FL-C-His

VcRctBD640RH642A-FLC-His
VcRctBR632AK633A-FLC-His
VcRctBH572RA573GS576A-FLC-His
VcRctBR530AR531A-FLC-His
VcRctBI643AD644AE645R-FLC-His

pET28b

Protein expression

RctB-D640R-H642A-for,
RctB-D640R-H642A-rev

This paper

pET28b

Protein expression

RctB-R632A-K633A-for,
RctB-R632A-K633A-rev

This paper

pET28b

Protein expression

RctB-H572R-A573GS576A-for, RctB-H572RA573G-S576A-rev

This paper

pET28b

Protein expression

RctB-R530A-R531A-for,
RctB-R530A-R531A-rev

This paper

pET28b

Protein expression

RctB-I643A-D644AE645R-for, RctB-I643AD644A-E645R-rev

This paper

VcRctBQ613AN614AE615R-FLC-His
VcRctBE615AK617AH618R-FLC-His

pET28b

Protein expression

RctB-Q613A-N614AE615R-for, RctB-Q613AN614A-E615R-rev

This paper

pET28b

Protein expression

RctB-E615A-K617AH618R-for, RctB-E615AK617A-H618R-rev

This paper

pNO054-pET28bVcRctB-R632AK633A-FL-C-His
pNO055-pET28bVcRctB-H572RA573G-S576A-FLC-His
pNO056-pET28bVcRctB-R530AR531A-FL-C-His
pNO057-pET28bVcRctB-I643AD644A-E645R-FLC-His
pNO058-pET28bVcRctB-Q613AN614A-E615R-FLC-His
pNO059-pET28bVcRctB-E615AK617A-H618RFL-C-His
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Primers

Citation

pNO060-pET28bVcRctB-T547PFL-C-His

VcRctBT547P-FLC-His

pET28b

Protein expression

RctB-T547P-for, RctBT547P-rev

This paper

pNO061-pET28bVcRctB-D586RW590R-R592AFL-C-His

pET28b

Protein expression

RctB-D586R-W590RR592A-for, RctBD586R-W590R-R592Arev

This paper

pNO062-pET28bVcRctB-K636AFL-C-His

VcRctBD586RW590RR592A-FLC-His
VcRctBK636A-FLC-His

pET28b

Protein expression

RctB-K636A-for, RctBK636A-rev

This paper

pNO063-pET28bVcRctB-S575AFL-C-His

VcRctBS575A-FLC-His

pET28b

Protein expression

RctB-S575A-for, RctBS575A-rev

This paper

pNO064-pET28bVcRctB-V630AR632A-FL-C-His

VcRctBV630AR632A-FLC-His

pET28b

Protein expression

RctB-V630A-R632A-for,
RctB-V630A-R632A-rev

This paper

pNO065-pET28bVcRctB-E560AT564A-FL-C-His

VcRctBE560AT564A-FLC-His

pET28b

Protein expression

RctB-E560A-T564A-for,
RctB-E560A-T564A-rev

This paper

pNO066-pET28bVcRctB-S555AE557A-FL-C-His

VcRctBS555AE557A-FLC-His

pET28b

Protein expression

RctB-S555A-E557A-for,
RctB-S555A-E557A-rev

This paper

pNO067-pET28bVcRctB-R649AFL-C-His

VcRctBR649A-FLC-His

pET28b

Protein expression

RctB-R649A-for, RctBR649A-rev

This paper

pNO068-pET28bVcRctB-Y600AFL-C-His

VcRctBY600A-FLC-His

pET28b

Protein expression

RctB-Y600A-for, RctBY600A-rev

This paper

pNO069-pET28bVcRctB-W590AR592A-N595AFL-C-His

VcRctBW590AR592AN595A-FLC-His
VcRctBS575AS576AE579A-FLC-His
VcRctBE594AN595A-FLC-His

pET28b

Protein expression

RctB-W590A-R592AN595A-for, RctBW590A-R592A-N595Arev

This paper

pET28b

Protein expression

RctB-S575A-S576AE579A-for, RctB-S575AS576A-E579A-rev

This paper

pET28b

Protein expression

RctB-E594A-N595A-for,
RctB-E594A-N595A-rev

This paper

pNO070-pET28bVcRctB-S575AS576A-E579A-FLC-His
pNO071-pET28bVcRctB-E594AN595A-FL-C-His
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pNO072-pET28bVcRctB-K617AH618A-FL-C-His

VcRctBK617AH618A-FLC-His

pET28b

Protein expression

RctB-K617A-H618A-for,
RctB-K617A-H618A-rev

This paper

pNO077-pUC1812x3-nt540-623

Three 12mer sites
(OriCII
nucleotides
540 through
623)
Six 12-mer
sites (OriCII
nucleotides
544 through
687)

pUC18

EMSA probe

12x3-OriCII-nt540-623for, 12x3-OriCII-nt540623-rev

This paper

pUC18

EMSA probe

OriCII-nt544-687-for,
OriCII-nt544-687-rev

This paper

pNO081-pUC1812x6-OriCII-nt544687
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Supplementary table 3.3. Primers.
Primer name
RctB-528-658-forward
RctB-528-658-C-His-STOP-r
RctB-D640R-H642A-for
RctB-D640R-H642A-rev
RctB-R632A-K633A-for
RctB-R632A-K633A-rev
RctB-H572R-A573G-S576A-for
RctB-H572R-A573G-S576A-rev
RctB-R530A-R531A-for
RctB-R530A-R531A-rev
RctB-I643A-D644A-E645R-for
RctB-I643A-D644A-E645R-rev
RctB-Q613A-N614A-E615R-for
RctB-Q613A-N614A-E615R-rev
RctB-E615A-K617A-H618R-for
RctB-E615A-K617A-H618R-rev
RctB-T547P-for
RctB-T547P-rev
RctB-D586R-W590R-R592A-for
RctB-D586R-W590R-R592A-rev
RctB-K636A-for
RctB-K636A-rev
RctB-S575A-for
RctB-S575A-rev
RctB-V630A-R632A-for
RctB-V630A-R632A-rev
RctB-E560A-T564A-for
RctB-E560A-T564A-rev
RctB-S555A-E557A-for
RctB-S555A-E557A-rev
RctB-R649A-for
RctB-R649A-rev
RctB-Y600A-for
RctB-Y600A-rev
RctB-W590A-R592A-N595A-for
RctB-W590A-R592A-N595A-rev
RctB-S575A-S576A-E579A-for
RctB-S575A-S576A-E579A-rev
RctB-E594A-N595A-for
RctB-E594A-N595A-rev
RctB-K617A-H618A-for
RctB-K617A-H618A-rev
12x3-OriCII-nt540-623-for
12x3-OriCII-nt540-623-rev
OriCII-nt544-687-for
OriCII-nt544-687-rev

Sequence
gatcatatgttaggtcggcgcgtgaagc
gtgggatccttaatgatgatgatgatgatgggctccagcggccatctcatc
ctcgatacaccgtttcgtcaatggccccacgttgaaccaatttacagactttac
gtaaagtctgtaaattggttcaacgtggggccattgacgaaacggtgtatcgag
catcttgaaccaatttacagactgcagcgcgtaccgctaaacctgcgatc
gatcgcaggtttagcggtacgcgctgcagtctgtaaattggttcaagatg
cactcttctttgattgctgaagggccgcgtccagtcatagccgc
gcggctatgactggacgcggcccttcagcaatcaaagaagagtg
ttacgtagcttcacggccgcacctaagcggcctctcgg
ccgagaggccgcttaggtgcggccgtgaagctacgtaa
catctaaggctcgatacaccgttctggcagcgtgcccatcttgaaccaatttac
gtaaattggttcaagatgggcacgctgccagaacggtgtatcgagccttagatg
cgatcgacagatgtttactcctagctgcgctgttgtagagctcaagcagcttgctcaat
attgagcaagctgcttgagctctacaacagcgcagctaggagtaaacatctgtcgatcg
gcgatcaatttttcgatcgacagacgtgcactcgcattttggctgttgtagagctc
gagctctacaacagccaaaatgcgagtgcacgtctgtcgatcgaaaaattgatcgc
gtataacgcgatagagtaatggggatttcatcagcattgatttcg
cgaaatcaatgctgatgaaatccccattactctatcgcgttatac
catcgttttcaacagccagcctatctagcttgcgtatgagctctacacactcttc
gaagagtgtgtagagctcatacgcaagctagataggctggctgttgaaaacgatg
gtgcccatcttgaaccaatgcacagactttacggcgtacc
ggtacgccgtaaagtctgtgcattggttcaagatgggcac
ctcttctttgattgatgcaggggcgtgtccagtc
gactggacacgcccctgcatcaatcaaagaagag
gaaccaatttacagactttagcgcgtgccgctaaacctgcgatcaa
ttgatcgcaggtttagcggcacgcgctaaagtctgtaaattggttc
gccgctaaagccgctatactgcgtgctagcgcttctgg
ccagaagcgctagcacgcagtatagcggctttagcggc
ctgcgttctagcgctgctggagcggtataacgcgatag
ctatcgcgttataccgctccagcagcgctagaacgcag
ctcatctaaggctgcatacaccgtttcgtcaatgtgccc
gggcacattgacgaaacggtgtatgcagccttagatgag
tgctcaatgtcggggcttggatcacatcgttttcaacacg
cgtgttgaaaacgatgtgatccaagccccgacattgagca
gggtattggatcacatcggcttcaacagccagcgcatctagcttgtctatgagctc
gagctcatagacaagctagatgcgctggctgttgaagccgatgtgatccaataccc
gctctacacactctgctttgattgctgcaggggcgtgtccagtc
gactggacacgcccctgcagcaatcaaagcagagtgtgtagagc
tcgggtattggatcacatcggctgcaacacgcagccaatctagc
gctagattggctgcgtgttgcagccgatgtgatccaatacccga
atttttcgatcgacagagctgcactctcattttggctgttgtagagctcaagcag
ctgcttgagctctacaacagccaaaatgagagtgcagctctgtcgatcgaaaaat
tcatgtcgacgatatcctgtgtgagcaccttgatcatgcttagaagcttacg
ttcaggatccgatatccatttgttcctctaagcatgatcatcagtcaacag
tcatgtcgacgatatcgtgagcaccttgatcatgcttagaagcttacg
gacgggatccgatatcgccattcagaagcatgatcatgtatcgatgg
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Supplementary table 3.4. EMSA probes.
EMSA probe

DNA sequence

Citation

12x6-short

ATCGTGAGCACCTTGATCATGCTTAGAAGCTTACGTTGATCATTG
ATTCTGTTGACTGATGATCATGCTTAGAGGAACAAATGATCATGC
TTTCGATCTTGTATTGATCATGGTTTCCATCGATACATGATCATGC
TTCTGAATGGCGAT
ATCCTGTGTGAGCACCTTGATCATGCTTAGAAGCTTACGTTGATC
ATTGATTCTGTTGACTGATGATCATGCTTAGAGGAACAAATGGAT
GCGGAAGCATGTAAATTCATTATCAATTTACGGTCGATG

This paper

12x3
inc39-short
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This paper
This paper

CHAPTER 4 – CONCLUSIONS
In conclusion, the research presented in this dissertation was focused on the
elucidation of the structural and biochemical aspects of DNA replication initiation of the
secondary chromosome in Vibrio cholerae. V. cholerae is a bacterial species that unlike
most of bacteria has two chromosomes. DNA replication initiation of the secondary
chromosome in V. cholerae requires a unique initiator protein, RctB, which is not similar
in its amino acid sequence to any other protein.

We aimed to collect structural

information in order to reveal the mechanism of bacterial DNA replication initiation,
using the secondary V. cholerae chromosome as a system of interest.
RctB is a 75 kDa protein. Domain composition of RctB was determined and the
structures of all four domains of RctB were solved using X-ray crystallography. The
structure of its central two domains resembles that of several plasmid replication
initiators. We demonstrated that RctB contains at least three DNA binding domains, and
integrity of each one of them is required for biological activity of RctB. In the structure,
RctB adopts a head-to-head dimeric configuration that most likely represents the
arrangement in solution. We hypothesize that RctB has to monomerize prior to binding
the replication origin. We showed that the affinity of monomeric RctB to OriCII is
higher, than the affinity of the wild-type dimeric protein, which suggests that the
availability of the pre-formed monomers promotes OriCII binding. We also showed that
both wild-type and monomeric RctB-D314P form intermediate protein-DNA complexes
with the same exact electrophoretic mobility, which suggests that the assembly of the
RctB-OriCII complex goes through the same intermediates regardless of the original
oligomeric state of RctB.
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The similarity of RctB’s middle core and plasmid initiators support the hypothesis
that the second Vibrionaceae chromosome could have evolved from a plasmid, and that
RctB could acquire additional regulatory features. The structural information about the
key three RctB domains and the information about the domains’ functions allowed us to
develop a model of a complete assembly that RctB forms on the replication origin.
The structure of the domain four of RctB was solved with X-ray crystallography
as well. There are two working hypotheses about the domain four function: it was
proposed to mediate RctB interaction with the regulatory binding sites (39-mer, rctA39mer, 29-mer), and it is proposed to mediate protein-protein interactions between adjacent
RctB molecules within the large RctB-OriCII complex. The work dedicating to testing
our hypothesis about domains four function is currently in progress and it is discussed in
chapter 3 of this dissertation.
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CHAPTER 5 – FUTURE DIRECTIONS
The work described in this dissertation produced the first structural view for the
secondary chromosomal DNA replication initiation machinery and laid out a strong
foundation for future structural studies of the RctB-OriCII complexes. The structural and
biophysical data obtained in the course of this work allowed us to develop a model of the
macromolecular complex; in which several molecules of RctB form on the replication
origin of the secondary V. cholerae chromosome.
The RctB structure provided greater understanding of the initiator function and
allowed us to design a monomeric RctB mutant. Using monomeric RctB protein (RctBD314P), we were able to obtain stable macromolecular RctB-DNA complexes.
Therefore, the main future direction of this research is to obtain a high-resolution
structure of the RctB-OriCII complex using cryo-EM.
The ability to prepare a suitable stable sample is a key obstacle for any structural
study; the fact that the RctB structure provided us with the tools to obtain stable proteinDNA complexes is extremely encouraging. There is no available high- or low-resolution
structure of a macromolecular assembly formed on E. coli’s main chromosome or an
assembly formed on the plasmid replication origin. Therefore, if the structure of the
complete assembly formed on the origin DNA by RctB would be elucidated, it would
become the first structure of bacterial replication origin-initiator complex. Obtaining a
premier view of the complete initiator-origin DNA assembly would be a huge milestone
for the understanding of the mechanistic details of bacterial DNA replication initiation.
The future EM work will include pursuing structures of several RctB-DNA
complexes in parallel: a DNA probe with 3 RctB binding sites (half of OriCII-min) and
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RctB, a DNA probe with 6 RctB binding sites (all the RctB binding sites from OriCIImin) and RctB, a DNA probe with 6 RctB binding sites (all the RctB binding sites from
OriCII-min), the DnaA binding site, RctB, and DnaA, and other probes. The structures of
the smaller complexes would provide information about the RctB-RctB contacts and
prove or adjust our hypothesis about the symmetry of RctB binding to origin DNA;
structures of the larger complexes would shed light on the mechanism of the unwinding
of the DNA double helix, such a complex should contain the complete OriCII-min
including the AT-rich region.
Another important direction of the project is the determination of a full RctB
binding site. It is reported that OriCIImin has six conserved 12-mers, which are
considered to be RctB binding sites. However, our structural studies suggest that the full
RctB binding site has to be larger than a 12-mer and include some of the spacer DNA,
forming a binding site of about 22 basepairs long. Determination of the full RctB binding
site will clarify the mode of RctB interaction with DNA. Importantly, determination of
the complete RctB binding site would allow us to pursue the structure determination of a
single RctB-DNA complex via x-ray crystallography.
One of the main obstacles for crystallization of protein-DNA complexes is the
determination of the appropriate DNA molecule; therefore, determination of the RctB
binding site would allow us to start the crystallization efforts for the RctB-DNA complex.
Our preliminary data with unmethylated DNA suggests that the full RctB binding site
includes the conserved 12-mer plus about 10 basepairs to the right of the conserved 12mer. These results have to be reproduced in the same conditions and also reproduced with
methylated DNA, since RctB binds to methylated binding site with grater affinity, and
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methylation of the 12-mers is required for RctB function in vivo. If these results prove to
be reproducible, crystallization trials with the DNA molecule containing the minimal
binding site will promptly be pursued.
Another important direction is investigation of the interaction between RctBOriCIImin complex and single-stranded DNA. The working hypothesis implies that when
RctB forms a macromolecular complex on OriCIImin a new surface with affinity to
single-stranded DNA forms, and that surface binds one of the strands of the AT-rich
region. The described mechanism is proposed for the E. coli DnaA based replication
system, and we hypothesize that the RctB-based replication system operates using a
similar mechanism. In order to test this hypothesis, EMSAs with radiolabeled singlestranded DNA from an A-T rich region will be used. Ultimately, a high-resolution EM
structure of OriCIImin-RctB complex bound to a single-stranded DNA (if such indeed
forms) would provide the most important mechanistic details of the DNA replication
initiation mechanism.
Lastly, there is a very important and interesting feature of the secondary
chromosomal replication that is missing structural details; the coordination in timing
between the primary and the secondary chromosomal replication. It was shown that the
coordinated replication depends on the RctB binding site that is located on the primary V.
cholerae chromosome (cit). It is hypothesized that RctB binds to both chromosomes and,
therefore, brings them together, which in turn triggers coordinated DNA replication
initiation. However, current understanding of this mechanism is very limited. It is very
important to elucidate the structural and mechanistic details of such a unique and
elaborate regulatory mechanism.
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In conclusion, the work described in this dissertation laid out a strong foundation
for in depth structural studies of the structural aspects of DNA replication initiation of the
secondary chromosome in V. cholerae. Obtaining a first view of the complete initiatororigin DNA assembly is one of the key directions for future work and it would provide
understanding of the mechanistic details of bacterial DNA replication initiation.
Determination of the minimal RctB binding site and obtaining a DNA-bound
RctB structure would help to validate our hypothesis about RctB-OriCII interactions.
Experiments with the RctB-OriCII complexes and single-stranded DNA from the A-T
rich region would reveal the mechanism of DNA melting. Finally, elucidation of the
coordination between the replication of the two chromosomes would provide
understanding of the specific features unique to multi-chromosomal bacteria. The
knowledge about the coordinated replication would contribute greatly to our
understanding of DNA replication mechanism in bacteria and, in particular, in multichromosomal bacteria.
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